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Tiivistelmä 
Mielenterveyden häiriöillä on laaja-alainen vaikutus nuoren elämään; koulume-
nestykseen, sosiaalisiin suhteisiin ja psyykkiseen sairastamiseen aikuisena. Ma-
sennustilat ovat kansanterveydellisesti merkittävin mielenterveyden ongelma 
nuorilla, mutta vain harva on hoidon piirissä. Tämän pitkittäistutkimuksen ta-
voitteena oli lisätä tietoa varhaisesta masennuksesta, sen yhteydessä esiintyvistä 
mielenterveyden häiriöistä ja päihteidenkäytöstä edustavassa suomalaisessa vä-
estöpohjaisessa aineistossa. Tutkimus on osa Suomalaista Kaksosten Kehitys ja 
Ter veys tutkimusta, jossa seurataan kaikkia Suomessa vuosina 1983-87 syntynei-
tä kaksosia 12, 14, 17½ ja 20-24 v iässä. Tässä tutkimuksessa käytetyt mielentervey-
den häiriöiden diagnoosit perustuivat 1852:n vuosina 1983-1987 syntyneiden 
14-vuotiaiden suomalaisen nuorten henkilökohtaiseen haastatteluun ja seuranta-
kyselyihin 12- ja 17½-vuoden iässä.
Tutkimuksessa todettiin, että vakavan masennuksen lisäksi myös nuorten haital-
lisiksi kokemat masennusoireet ovat tärkeä nuorten kehitykseen vaikuttava teki-
jä. Vakavan masennuksen diagnostiset kriteerit eivät tavoita suurinta osaa ma-
sentuneista nuorista. Lievät masennustilat, jotka aiheuttavat toiminnallista hait-
taa mm. kouluympäristössä ja toverisuhteissa, mutta eivät täytä vakavan masen-
nuksen kriteerejä altistavat mm. itsetuhoisuudelle, muille mielenterveyden häi-
riöil le ja päihteidenkäytölle. Tässä tutkimuksessa osoitettiin, että nuoruusiän 
ma sennus ennustaa merkittävästi päivittäistä tupakointia, usein toistuvaa alko-
holinkäyttöä, säännöllistä humalajuomista sekä nuuskan ja huumeiden käyttöä, 
kun muut mielenterveydenhäiriöt, käytöshäiriöt ja jo 14-v alkaneet päihdehäiriöt 
ote taan huomioon. Masennuksen ja päihteidenkäytön yhteys on todettavissa 
myös riippumatta yhteisistä perheittäisistä tekijöistä, kuten yhteisestä perimästä 
ja yhteisestä perheympäristöstä eli esimerkiksi perheen toimeentulosta. Tutki-
mustulokset viittaavat siihen, että ei-perheittäiset tekijät, kuten nuoren persoonal-
li suus ja kouluympäristöön sekä toverisuhteisiin liittyvät tekijät saattavat olla 
mer kityksellisiä masentuneen nuoren päihteidenkäytön kehittymisessä.
Tutkimuksessa todettiin ensikertaa suomalaisessa väestöpohjaisessa pitkittäis-
ase telmassa huomattava yhteissairastavuus tyttöjen masennuksen ja tarkkaavai-
suushäiriön (ADHD:n) välillä, mikä saattaa olla osasyynä vaikeuteen tunnistaa 
tyt töjen tarkkaavaisuushäiriön oireita. Vanhempien ja opettajien arvioimina nä-
mä oireet; keskittymisen vaikeudet, yliaktiivisuus ja impulsiivisuus olivat tytöil-
lä selvästi poikien oireita harvinaisempia. Silti ADHD oireet olivat selkeä  tyttöjen 
kehitystä vaarantava tekijä; tässä tutkimuksessa ne ennustivat alkoholin haitallis-
ta käyttöä, alkoholiriippuvuutta sekä huumausaineiden tulevaa käyttöä selvästi 
mer kittävämmin kuin poikien ADHD-oireet.
Jatkossa on tärkeää selvittää, voitaisiinko masennusta ja muita varhain alkavia 
tai kehityksellisiä mielenterveyden häiriöitä paremmin tunnistamalla ja hoita-
malla vaikuttaa päihteidenkäytön kehittymiseen. Myös lievemmät  masennustilat, 
jotka aiheuttavat toiminnallista haittaa mutta eivät täytä vakavan masennuksen 
oire kriteerejä altistavat mm. päihteidenkäytön merkittävälle lisääntymiselle ja 
niil lä saattaa korkeamman esiintyvyytensä vuoksi olla huomattava kansantervey-
dellinen merkitys. Tyttöjen ja poikien alttiudessa päihteidenkäytön kehittymi-
selle saattaa olla eroja, ja tätä tulisi päihteidenkäytön ehkäisyä ajatellen tutkia 
li sää. Psykiatrisen hoidon ja päihdehoidon yhteistyötä nuorilla tulee kehittää.
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Abbreviations
ADHD   attention deficit/hyperactivity disorder
APA    American Psychiatric Association
C-SSAGA Semi-Structured Interview for Genetics of Alcoholism 
CI     confidence interval
DSM-III-R Diagnostic and Statistical Manual of Mental Disorders,  
     3rd edition, revised
DSM-IV  Diagnostic and Statistical Manual of Mental Disorders, 4th edition
DD    depressive disorders
ED    eating disorders
FINHCS Finnish Health Care Survey
FinnTwin12 Finnish Twin Study, suom. Kaksosten Kehitys ja Terveys
GAD    generalized anxiety disorder
MDD   major depressive disorder
ODD    oppositional defiant disorder
OR    odds ratio
SD    standard deviation
UKKI   The Uusikaupunki-Kemijärvi-Study
WHO   World Health Organization
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1. Abstract
Aims
Early-onset psychiatric illnesses’ effects scatter to academic achievements as well 
as functioning in familial and social environments. From a public health point of 
view, depressive disorders are the most significant mental health disorders that 
begin in adolescence. Using prospective and longitudinal design, this study 
aimed to increase the understanding of early-onset depressive disorders, related 
mental health disorders and developing substance use in a large population-de-
rived sample of adolescent Finnish twins. 
Methods
The participants of this study, FinnTwin12, an ongoing longitudinal population-
based study, came from Finnish families with twins born in 1983-87 (exhaustive 
of five birth cohorts, identified from Finland’s Central Population Register). With 
follow-up ongoing at age 20-24, this thesis assessed adolescent mental health in 
the first three waves, starting from baseline age 11-12 to follow-ups at age 14 and 
17½. Some 5600 twins participated in questionnaire assessments of a wide range 
of health related behaviors. Mental health was further assessed among an inten-
sively studied subsample of 1852 adolescents, who completed also professionally 
administered interviews at age 14, which provided data for full DSM-IV/III-R 
(Diagnostic and Statistical Manual for Mental Health disorders, 4th and 3rd edi-
tions) diagnoses. The participation rates of the study were 87-92%. 
Results
The results of the study suggest, that the diagnostic criteria for major depressive dis-
order (MDD) may not capture youth with clinically significant early-onset  depressive 
conditions outside clinical settings. Milder cases of depression, namely adolescents 
fulfilling the diagnostic criteria for minor depressive disorder, a qualitatively  similar 
condition to MDD with fewer symptoms are also associated with marked suicidal 
thoughts, plans and attempts, recurrences and a high degree of comorbidity. Pro-
spectively and longitudinally, early-onset depressive disorders were of substantial 
importance in the context of other mental health disorders and substance use behav-
iors: These data from a large population-derived sample established a  substantial 
overlap between early-onset depressive disorders and  attention deficit  hyperactivity 
disorder in adolescent females, both of them significantly predictive for  development 
of substance use among girls. Only in females baseline DSM-IV ADHD symptoms 
were strong predictors of alcohol abuse and  dependence and illicit drug use at age 14 
and frequent alcohol use and illicit drug use at age 17.½ when conduct disorder and 
previous substance use were controlled for. Early-onset depressive disorders were 
also prospectively and longitudinally associated to daily smoking behavior, smoke-
less tobacco use, frequent alcohol use and illicit drug use and eating  disorders. Anal-
ysis of discordant twins suggested that these predictive associations were independ-
ent of familial confounds, such as family income, structure and parental models. 
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Conclusions
In sum, early-onset depressive disorders predict subsequent involvement of sub-
stance use and psychiatric morbidity. A heightened risk for substance use is sub-
stantial also among those depressed below categorical diagnosis of MDD. Wheth-
er early recognition and interventions among these young people hold potential 
for substance use prevention further in their lives has potential public health 
significance and calls for more research. Data from this population-derived sam-
ple with balanced representation of boys and girls, suggested that boys and girls 
with ADHD behaviors may differ from each other in their vulnerability to sub-
stance use and depressive disorders: the data suggest more adverse substance 
use outcome for girls that was not attenuated by conduct disorder or previous 
substance use. Further, the prospective associations of early-onset depressive 
disorders and future elevated levels of addictive substance use is not explained 
by familial factors supporting future substance use, which could have important 
implications for substance use prevention. 
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2. List of original publications
This thesis is based on the following original publications, referred to in the text 
by Roman numerals (I–IV):
I  SIHVOLA E, KESKI-RAHKONEN A, DICK DM, PULKKINEN L, ROSE RJ, 
MARTTUNEN M, KAPRIO J. MINOR DEPRESSION IN ADOLESCENCE: 
PHENOMENOLOGY AND CLINICAL CORRELATES. JOURNAL OF AF-
FECTIVE DISORDERS 2007; 97:211-8.
II  SIHVOLA E, ROSE RJ, DICK DM, KORHONEN T, LEPPÄMÄKI S, RAE-
VUORI A, PULKKINEN L, MARTTUNEN M, KAPRIO J. ARE GIRLS WITH 
SYMPTOMS OF ADHD AT HIGHER RISK FOR SUBSTANCE USE THAN 
BOYS?-PROSPECTIVE FINDINGS FROM A POPULATION-DERIVED 
SAMPLE OF GIRLS AND BOYS. SUBMITTED.
III: SIHVOLA E, ROSE RJ, DICK DM., PULKKINEN L, MARTTUNEN M., KA-
PRIO J. EARLY-ONSET DEPRESSIVE DISORDERS PREDICT THE USE OF 
ADDICTIVE SUBSTANCES IN ADOLESCENCE: A PROSPECTIVE STUDY 
OF ADOLESCENT FINNISH TWINS. ADDICTION 2008; 12:103; 245-253.
IV: SIHVOLA E, KESKI-RAHKONEN A, DICK DM, PULKKINEN L, ROSE RJ, 
MARTTUNEN M., KAPRIO J. PROSPECTIVE ASSOCIATIONS OF AXIS-1 
DISORDERS AND DEVELOPING EATING DISORDERS. COMPREHEN-
SIVE PSYCHIATRY 2009; 50:20-5. 
 
The reprints are reproduced with the permission of copywright holders.
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3. introduction
In Finnish society, psychiatric disorders among children and adolescents are still 
undetected and therefore undertreated. A substantial public health concern is 
expressed, since many studies document a possible association between psychi-
atric morbidity and substance use. Cross-sectional studies provide valid and use-
ful information, but as many psychiatric disorders are lifespan and dynamic by 
nature, longitudinal studies assessing both space and time are of importance in 
the research of psychopathology.
It is well documented that depressive disorders are one of the leading causes of 
disability and ill health in Finnish population. This disease affects to individual’s 
overall health, academic and working performance, social relationships and may 
sometimes contribute to one of the highest rates of suicide worldwide(Pelkonen 
& Marttunen, 2003a), especially when untreated (Birmaher et al., 1996).However, 
depressive disorders start early in life, and previous literature does not cover suf-
ficiently younger age groups, especially adolescents, who are in a critical devel-
opmental period for studying depression (Pelkonen and Marttunen, 2003b). Fur-
ther understanding of the developmental context of depression during these 
years; it’s variability of symptoms and comorbidity will be necessary in develop-
ing effective interventions to young people thus enabling them to reach their full 
potential as adults (Rao & Chen 2009).
Recent studies suggest that the incidence of depressive symptoms is rising among 
8-9-year-old Finnish girls (Lapset-study, Almqvist et al., 1999). Some but not all 
large-sample surveys also suggest that the prevalence of depressive symptoms is 
increasing (Klerman & Weismann 1989, Kovacs et al., 1994, Witchen et al., 1994a, 
 Kessler et al., 1994), the age of onset dropping (Lewinsohn et al., 1993a). This po-
tential cohort effect is consistent with the concomitant rise in the youth suicide 
rate from 1950’s to 1990s (Costello et al., 2006).Thus, studies using epidemiologic 
perspective are of vital importance when planning satisfactory health care 
 services for adolescents. 
Depression relates to other psychiatric disorders and they have potential effects 
on worsening treatment response and outcome of depression (Howland, 2009). It 
seems, that having another distinct disorder along with depressive illness, causes 
more severe and chronic natural course and associates to increased treatment 
seeking (Newman et al., 1996, Witchen et al., 1998, Kessler at al., 1998a). Previous 
research suggests that the most important co-occurring disorders among adoles-
cents and young adults with depression are anxiety disorders, disruptive dis-
orders; such as conduct disorder, and oppositional-defiant disorder and  substance 
use disorders (Biederman et al., 1995, Birmaher et al., 1996, Kessler at al., 2001). 
Clinical studies are of great importance; however, they might only provide infor-
mation on those whose seek treatment. Assessing concurrent comorbidity offers 
limited information, and understanding longitudinal relationships is necessary 
for preventive actions. 
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Youth also marks a period crucial for developing substance use habits. Once 
these deviant behaviors are established, they are likely to continue throughout 
adulthood. There are studies, which suggest that if substance used is not initiated 
by age 21, it is unlikely to ever be initiated (Chen and Kandel, 1995). In many 
countries, smoking and drinking cause a significant public health concern among 
adolescents. Based on clinical experience, in young psychiatric patients the prev-
alences of deviant behaviors such as smoking, alcohol and illicit drug use are 
known to be very high. Even though majority of adolescents do not develop sub-
stance use disorders, the use of these addictive substances has been suggested to 
have similar impact for mental health as substance use reaching the diagnostic 
threshold. Given the high comorbidity of adolescent depression, it is also of great 
importance to look for potential mediators, the factors that associate to depres-
sion and may promote the substance use itself. Few longitudinal studies have 
been conducted in adolescence, in a developmental period in which both depres-
sive disorders and substance use emerge. Determining these important pathways 
may help to identify unique or common risk factors, clarify the etiologic and 
pathogenic mechanisms and provide information for developing guidelines for 
preventive actions and treatment programs.
This study is a part of an ongoing longitudinal Finnish Twin Study, launched in 
1994 to investigate the developmental genetic epidemiology of health-related be-
haviors (Rose et al., 2001). From 1994 to 1998, all Finnish families with twins born 
in 1983-87 were identified from Finland’s Population Register Centre and en-
rolled into a two-stage sampling design (Kaprio et al., 2002). The first-stage study 
included questionnaire assessments of all twins and parents at baseline (87% 
participation rate, 2,724 families) conducted during the late autumn of the year in 
which consecutive twin cohorts reached 11 years, with follow-up of all twins at 
ages 14 and 17½ and ages 20-24. The prior investigations of this unique sample 
have provided genetic epidemiology data on wide range of substance use (e.g., 
Rose et al.,2001, Rose et al., 2004, Dick et al., 2007, Korhonen et al., 2008) on aggres-
sion and hyperactivity impulsivity traits (Vierikko et al., 2004 ), inattentiveness 
and smoking (Barman et al.,2004 ), parental socialization and alcohol use behav-
iors, pubertal development (Mustanski et al., 2004, Wehkalampi et al., 2008) and 
leisure activity patterns and overweight (Lajunen et al., 2009), obesity and eating 
disorders (Keski-Rahkonen et al., 2007, Raevuori et al., 2008). This thesis focused 
in the first three waves of FinnTwin12, studying prospective longitudinal asso-
ciations of early-onset depressive disorders with and developing substance use 
and psychiatric morbidity. Two of the substudies were complimented by twin 
analysis of discordant twins controlling shared and environmental factors aim-
ing to offer added value to epidemiologic perspective of these diseases. 
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4. Review of the literature
4.1. Overview of psychiatric epidemiology and longitudinal 
studies among adolescents
Longitudinal studies are essential of testing causal hypothesis and planning 
services. Some key studies have established the value of prospective assessments 
in the field of adolescent psychiatry; beginning with the California longitudinal 
studies (Elder, 1974, 1998) and the first British Birth Cohort study (Douglas, 1964). 
More recently, the Dunedin and Christchurch studies, “Children in the Commu-
nity” (Cohen and Brook, 1987, Cohen and Cohen, 1996) have provided evidence of 
the links and disruptions between child and adult psychopathology. These stud-
ies are characterised by good generalizability due representative sampling, and 
their capability to study environmental factors and the outcome of behaviours 
below the diagnostic threshold. The Isle of Wight Studies (Rutter et al., 1970, Rut-
ter 1989b) have been innovative in showing the value of children as informants of 
their own psychopathology, and in line with other important studies (Richman 
et al., 1982), in demonstrating the precursorial nature of early psychopathological 
problems to later psychiatric morbidity. Large scale studies also provide the 
much needed estimates for service need in populations (Meltzer et al, 2000) and 
the information on mixed patters of symptoms and how they chance over time. 
Contemporary psychiatric epidemiology also aims to gather information on risk 
and protective factors with regard to psychopathology, and the pathways and 
mechanism through they operate (Laub and Sampson, 2003). Although not focus-
ing on adolescents, two large epidemiological studies, The Epidemiologic Catch-
ment Area Study (ECA) (Robins et al., 1991) and National Comorbidity Survey 
(NCS) (Kessler et al., 1994) are have been of great importance in established the 
modern methods, introducing reliable lay-administered structured diagnostic 
assessments, and the application of sampling strategies.
An advanced scope in psychiatric epidemiology is to study more rare or subtle 
psychopathology, which can be achieved by psychiatric epidemiology high-risk 
studies. For example, the study of Owens’ and Johnstone’s (2006) examined the 
prodromal phase of schizophrenia in a high-risk schizophrenia sample. These 
designs are obviously limited by the uncertainty of these factors associating to 
high family loading, and it of importance to combine the high risk data to epide-
miological data. Alternatively, designs can be planned that embed the high-risk 
sample within epidemiological design (Moffit, 2002). Longitudinal studies of ad-
olescents are conducted also in Finland; From a Boy to a Man”; a follow-up study 
(Sourander et al,, 2008) included in the Epidemiologic Multicenter Child Psychi-
atric Study (Almqvist et al.., 1999) and substudies of mental health from Northern 
Finland Birth Cohorts (NFBC), starting from early development have greatly in-
creased the knowledge on longitudinal aspects of adversities of mental health 
among Finnish adolescents (Isohanni et al., 2001, 2006, Riala et al., 2007, Hurtig et 
al., 2007, Jääskeläinen et al., 2008). 
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4.2 Overview of normative adolescent development
Adolescence can be described as a period of transition from childhood to adult-
hood. During adolescence, individuals face both important biological and psy-
chological developmental tasks, a sequential process that may be compromised, 
delayed or even hindered by mental disorders. 
A number of theories of development in adolescence are widely recognized. For 
example, Blos (Blos 1979) described adolescence as “the second individuation 
process”, referring to the chance to recap the separation-individuation phase of 
early childhood. According to Moses Laufer (Laufer 1975), a new perception of 
self and others develops: this is experienced as part of the pressure to move to-
wards adulthood and as part of giving up safety and dependency of one’s child-
hood. Perhaps one of the most widely known theories of development is the one 
created by Erik Erikson in 1968 (Erikson, 1968) who described the formation of 
identity in adolescence. According to Erikson, during adolescence, the primary 
developmental task is to find out who one is as an individual, separate from our 
family. Jean Piaget, a Swiss psychologist described adolescence as the last phase 
of cognitive development called “the formal operational stage” , which often lasts 
from age eleven on, a period when adolescents learn how to think more abstract-
ly to solve problems, to think symbolically and develop the ability to use propo-
sitional logic, inductive and deductive logic, and combinatorial reasoning.
In adolescence, three phases, early, middle and late adolescence can be distin-
guished. (Aalberg and Siimes, 1999, Marttunen and Rantanen, 2001).In the begin-
ning of early adolescence around age 12, the physical changes, accelerating 
growth, puberty and development of female or male secondary sex characteris-
tics emerge. At the same time, adolescent starts the separating process from fam-
ily and identifies with peers. The middle adolescence, ages 14-17, is characterized 
by consolidation of self sense while the sense of threat experience from adults is 
diminished. In mid-adolescence, many adolescents experience the first sexual en-
counters. The late adolescence, around ages 17-21 is a period when a more adult-
like life begins, some adolescents already leave their childhood home, academic 
and occupation choices are made and adolescents have the ability to commit to 
romantic relationships. The normal development consist great variability in time 
frames and between individuals.
4.3 Overview of early-onset depressive disorders
Before the late 1970s, the existence of depressive disorders in children and in ado-
lescents was controversial and depression was viewed as a predominantly adult 
disorder. After that, a growing body of evidence has established that depressive 
disorders are experienced by children and adolescents and that the current diag-
nostic criteria can be applied successfully to them (Birmaher et al., 1996). 
There is evidence from different childhood risk factors between juvenile-onset 
and adult-onset MDD suggest two distinct conditions (Jaffee et al., 2002). Despite 
similarity of clinical picture, there are differences in neurobiological correlates 
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and treatment responses between adults and adolescents (Kaufman et al., 2001). 
Future scientific challenges lie in understanding the etiology of early-onset de-
pressive disorders assessing possible neuropsychological processes and mecha-
nisms behind these illnesses (Goodyer, 2008). 
Depressive disorders are rare in childhood, but the rates rise considerably from 
early teens (Glowinski et al., 2003); possibly due hormonal changes emerging in 
puberty (Angold, et al., 1999b). Social information process, changes in brain phys-
iology (Nelson et al., 2005) and gene-environment correlations may also contrib-
ute to substantial increase of depression among teen-agers (Rice et al., 2003). At 
the onset of puberty, a dramatic female predominance for depressive disorders 
emerges, for the first time and the earlier onset of the puberty seem to increase 
the risk for depression and other disorders (Graber et al., 2004.). Possible causes 
for the sex-specific vulnerability have been suggested; higher tendency to rumi-
nate, higher rates of anxiety and increased interpersonal sensitivity in females as 
well as differences in cortisol metabolism between sexes (Breslau et al., 1995, No-
len–Hoeksma et al., 1999, Stroud et al., 2004.) Prepubertal depression is not well 
studied, a comorbid presentation with conduct disorder has been suggested 
(Harrington et al., 1997) but there might also be a less common, more severe fa-
milial type of depression among those children (Harrington, 2000). Prepubertal 
depression implies heterogeneity of early-onset depressions: it is associated with 
lower risk of recurrence, higher risks of suicidal attempts, bipolar disorder and 
alcohol dependence and lower heritability (Weismann et al., 1999)
Early-onset depressive disorders are associated with significant functional im-
pairment (Puigh –Antigh et al., 1993) and recurrence: 50-70% within 5 years of 
depressed children and adolescents will develop a recurrence within 5 years. The 
clinical relevance of early-onset MDD is underscored in previous literature, 5 to 
10% of will complete suicide within 15 years of their initial episode of major de-
pression (Rao et al., 1993) and early-onset depressive disorders have been de-
scribed as potential phenotype for suicidal behaviour (Mann et al., 2009).
4.4. Epidemiology of depressive disorders in adolescence
4.4.1 Prevalence of depressive symptoms and disorders among 
Finnish adolescents
Many domestic studies with have assessed depressive disorders in older adoles-
cent and adults (The Mini-Finland Health Survey; Lehtinen et al., 1990a, UKKI 
Study; Lehtinen et al., 1990b, Isometsä et al., 1997, Lindeman et al., 2000, The 
Health 2000 Study, Aalto-Setälä et al., 2002, Aromaa and Koskinen 2002 and Su-
visaari et al., 2009,) confirming that depressive disorders are indeed common and 
disabling diseases. Yet there are very few studies describing epidemiological 
data for younger adolescents. Starting in 1996, The Finnish Health Care Survey 
(FHCS96) established a 12-month prevalence of major depressive episodes of 5.3% 
assessing 509 adolescents aged 15-19 year olds (Haarasilta et al., 2001). Based on a 
handful of studies, that depressive symptoms seem to be common among adoles-
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cents, in questionnaire assessments of 600 adolescents the prevalence was 17, 2% 
(Aalto-Setälä et al., 2002). School-based survey questionnaires have established 
similar trends for depressive symptoms; prevalences were 18, 4% for girls and 
11.1% for boys (Fröjd et al., 2008). In 8-9 year-olds, parents reported the prevalence 
of 6.2 % for their offspring as being depressed. (Almqvist et al., 1999).
In Finland, these also seem to be changes in epidemiological trends, from 1989 to 
2005, self-reported depressive symptoms had increased among girls (Almqvist et 
al., 1999, Sourander et al., 2008). 
4.4.2 Prevalence of depressive symptoms and disorders among 
adolescents; International studies
In other countries, nationwide surveys have been conducted throughout adoles-
cence. In large-sample studies, the prevalence of major depressive disorder in 
adolescence has been estimated to range from 0.4% to 8.3% (Lewinsohn et al., 
1994, Birmaher et al., 1996). Studies across adolescence show up to 25% lifetime 
prevalence of major depressive disorder by the end of adolescence (Lewinsohn et 
al., 1993, Kessler et al., 2001, Costello et al., 2003, Fergusson et al., 2005) and from 
1% under age 12 to 17.4% at age 19 and older females (Glowinski et al., 2003). The 
Dunedin Study reported a one-year- prevalence of depression at age 11 was 1.8%, 
and increased to 4.3 at the age of 15 (Anderson et al., 1987, McGee et al., 1990). 
Taken into account the heterogeneity of methodologies and instruments used, it 
seems that in early and middle adolescence the prevalences of unipolar depres-
sive disorders generally vary from 1 to 10%, being lowest in early adolescence. 
4.5 Diagnosis of depressive disorders in adolescence 
4.5.1 Assessments of adolescent depression
For young people, the term depression is used to describe many different condi-
tions, perhaps of very variable nature. Interpretation of different cut points of 
symptoms scales, different instruments and scales yields different results. When 
this is combined with a heterogeneity of depression; its’ melancholic and atypical 
features, likely different symptom profiles in boys and girls, high comorbidity 
typical for adolescents and cultural variation (Weisman et al., 1996) the results 
may vary widely and be difficult to compare. To overcome this, instead of using 
self-reports with high sensitivity but low specificity, semi-structured and struc-
tured interviews have proven useful. The semi-structured interviews allow ad-
ditional questions and resemble more clinical assessments compared to struc-
tured interviews. However, semi-structured interviews may not be as cost-effec-
tive as structured interviews, since they require clinical experience. 
There seem to be substantial discrepancy between reports of teachers and par-
ents compared those of adolescents themselves (Roberts et al., 1998, Wu et al., 
1999), as symptoms may exist in different environments, e.g. home, school, or 
may be different by nature in specific environments. The internalizing symp-
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toms, such as in depressive disorders may not be noticed by parents or teachers 
which makes adolescents more reliable informants and supports the use of direct 
interviews (Fleming and Offord., 1990, Wu et al., 1999). However, adolescents may 
also exaggerate their substance use level among peers, which needs to studied 
further since perceptions of peer substance could predict substance use initiation 
and escalation (D’amico and McCarthy, 2006) A heightened need for peer ap-
proval as well as separation from family (Steinberg, 1993) emerges during adoles-
cence, causing, perhaps, an adolescent to be more unwilling to discuss the symp-
toms with parents. For example, suicidal ideation is rarely endorsed by parents 
(Rice et al., 2007).
4.5.2 Classification of subthreshold depressions 
Previous research states that diagnostic criteria for major depressive disorders 
can be applied to adolescents (Roberts 1995, Birmaher et al., 1996). However, 
many depressed adolescents seem to be left below the diagnostic threshold (Kes-
sler et al., 1994, Kessler and Walters 1998, Angold et al., 1999),Concerningly, im-
pairment and outcome of these adolescents may not differ from those with MDD 
but many of adolescents in need for interventions may not be considered when 
planning health care services.
The research interest for subthreshold depressive conditions has escalated, at a 
time when the quality of life and prevention of diseases have come into public 
health focus. It is well acknowledged that these conditions are a predisposing 
factor for major depressive disorders, (Georgiades et al., 2006) but the concept of 
subthreshold depression is too broad (Cujpers and Smith, 2004.) 
Minor depression, a depressive condition with impairment and distress caused 
by depressive symptoms, but with too few symptoms to qualify for a diagnosis 
of major depressive disorder, is included to one of the residual categories of Diag-
nostic and Statistical Manual of Mental Disorders-Fourth Edition-Text Revised 
(DSM-IV-TR, American Psychiatric Association) Depressive Disorder NOS. This 
condition is important, because it is significantly related to MDD in adulthood 
(Kessler et al., 1997). Research from adults suggest, that minor depression may 
occur either independently of a lifetime history of major depressive disorder or 
as a stage of illness in the course of recurrent unipolar depressive disorder (Ra-
paport et al., 2002).; In a study of Gonzalez-Tejera et al. (2005), adolescents with 
minor depression had similar outcomes when compared to those meeting full 
criteria for MDD in terms of psychosocial correlates and comorbidity.One of the 
previous studies, National Comorbidity Survey (NCS) reports a lifetime minor 
depression prevalence of as high as 9.9 % in adolescents and an almost identical 
course and outcome as MDD (Kessler et al., 1994, 1997). A growing body of evi-
dence supports the importance of this diagnosis included in DSM-V, but more 
surveys are encouraged to assess the relevance of this condition.
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4.5.3 The diagnostic criteria for major and minor depressive 
disorder in adolescence according to DSM-IV
TABLE 1. DSM-IV CRITERIA FOR MAJOR DEPRESSIVE DISORDER. MINOR DEPRESSIVE 
DISORDER HAS THE SAME CRITERIA AS MAJOR DEPRESSIVE DISORDER, BUT ONLY 2-4 DE-
PRESSIVE SYMPTOMS ARE PRESENT,ONE OF THEM BEING DEPRESSED/IRRITABLE MOOD, OR 
LOST OF PLEASURE (ANHEDONIA) DURING A TWO-WEEK PERIOD.
A.	A minimum of five symptoms from the following list have been present dur-
ing the same 2-week period and represent a change from previous function-
ing. One of the symptoms must be #1 or #2, as listed below
1)	 Depressed	mood	most	of	the	day,	nearly	every	day,	as	indicated	either	by	subjec-
tive	report	(e.g.	feels	sad	or	empty)	or	observation	made	by	others	(e.g.	appears	
tearful)
2)	Markedly	diminished	interest	or	pleasure	in	all,	or	almost	all,	activities	most	of	the	
day,nearly	every	day,as	indicated	either	by	subjective	account	or	observation	made	
by	others.	
3)	 Significant	weight	loss	when	not	dieting	or	weight	gain	(e.g.a	change	of	more	than	
5%	of	body	weight	in	a	month)	or	decrease	or	increase	in	appetite	nearly	every	day
4)	 Insomnia	or	hypersomnia	nearly	every	day
5)	 Psychomotor	agitation	or	retardation	nearly	every	day	(observable	by	others,not	
merely	subjective	feelings	of	restlessness
6)	 Fatigue	or	loss	of	energy	nearly	every	day
7)	Feelings	 of	 worthlessness	 or 	excessive	 or 	inappropriate	 guilt	 (which	 may	 be	
	delusional)	nearly	every	day	(not	merely	self-reproach	or	guilt	about	being	sick)
8)	Diminished	ability	to	think	or	concentrate,	or	indecisiveness,	nearly	every	day	(ei-
ther	by	subjective	account	or	as	observed	by	others)
9)	Recurrent	 thoughts	 of	 death	 (not	 just	 fear	 of	 dying),	 recurrent	 suicidal	 ideation	
without	a	specific	plan,or	a	suicideattempt	or	specific	plan	for	committing	suicide
B. The symptoms do not meet the criteria for a mixed episode
C. The symptoms cause clinically significant distress or impairment in social, 
occupational, or other importantareas of functioning
D. The symptoms are not due to the direct physiological effects of a substance 
(e.g., a drug of abuse, a medication)or a general medical condition (e.g., hy-
pothyroidism)
E. The symptoms are not better accounted for by bereavement, i.e., after the 
loss of a loved one, the symptoms persist for longer than 2 months or are 
characterized by marked functional impairment, morbid preoccupation, 
worthlessness, suicidal ideation, psychotic symptoms, or psychomotor re-
tardation
Lähde:	The	American	Psychiatric	Association,	http://www.psych.org
In adolescents, the criteria according to DSM-IV (APA, 1994) for major depressive 
disorder (MDD) are similar as in adults, with two exceptions. First, depressed 
mood as core phenomena may be replaced by irritability. Second, the duration of 
dysthymia is only 1 year compared to 2 years in adults. Taken that into account; 
diagnostic requirements are depressed/irritable mood or loss of interest or pleas-
22
Early-onset depressive disorders, related disorders and substance use
ure (anhedonia) for at least two weeks plus four additional symptoms, fatique or 
loss of energy, feelings of worthlessness, inappropriate guilt, impaired concen-
tration; significant weight loss or gain, increased/decreased appetite, insomnia 
or hypersomnia, psychomotor agitation or retardation, suicidal ideation or at-
tempts, a significant impairment of functioning and exclusion of bereavement 
and symptoms attributed to the effects of medication or alcohol use.
The criteria for minor depressive disorders, a residual category of Depressive 
Disorders NOS in DSM-IV (APA, 1994) are similar than in major depressive dis-
order except that only two to four symptoms are required. This diagnostic cate-
gory has not been evaluated among Finnish adolescents before, therefore no com-
parison data exist. 
4.6 Psychiatric disorders related to depressive disorders 
among adolescents
4.6.1 The concept of comorbidity and its’ relevance in  
depressive youth
Three decades ago, a concept of comorbidity was coined by a Yale epidemiologist 
Alvin Feinstein (Feinstein, 1970). Ever since it has provoked criticism and the use 
of the term is more or less controversial. Some researchers (Lilienfield et al., 1994) 
have stated that the term could only be valid in the context of well understood 
diseases and that the use of this term would not be appropriate unless both con-
ditions are underpinned by a discrete causal agent. 
Comorbidity is defined by co-occurrence of two or more distinct disorders in a 
same individual more often than expected by chance in a period of time (Kler-
man, 1990, Caron & Rutter 1991, Angold et al., 1999a). However, arbitrary diagnos-
tic cutting points are criticized (Waldman and Lilienfield, 2001). The rates of co-
morbidity vary extensively depending the study population and diagnostic proce-
dures and whether lifetime or current comorbidity is assessed. Previous research 
suggest that comorbidity is of special interest among depressed youth because it 
may associate to psychosocial impairment (Lewinsohn et al., 1995, Newman et al., 
1996, Wittchen 1996), suicidality (Marttunen et al., 1991, Lewinsohn et al., 1995) 
and treatment seeking (Fergusson et al., 1993, Lewinsohn et al., 1995, Aalto-Setälä 
et al., 2002, Haarasilta et al., 2002). Surprisingly, whether or not comorbidity affects 
or moderates treatment outcomes has not been addressed in most studies examin-
ing comorbidity during childhood and adolescence. (Ollendick, 2008). The earlier 
the onset, the more frequently comorbidity has been observed (Klein et al., 1999, 
Alpert et al., 1999). The estimates of prevalences among children and adolescents 
with depressive disorders are high, from 40 to 90 percent(Angold and Costello, 
1993, Rohde et al.,1991, Kovacs, 1996, Biederman et al., 1995) Of adolescents with 
major depressive disorder, 40-80% have also at least one comorbid disorder, most 
likely an anxiety disorder (30-80)%, a disruptive disorder (30-80)% or a substance 
use disorder(20-30)% (Anderson and Mc Gee 1994, Birmaher at al., 1996). 
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Data concerning the longitudinal relationships of early-onset depressive disor-
ders is sparce. Previous research shows that depression in adolescence predicts 
further episode of major depression and may be converted to bipolar disorder 
(Kovacs 1996, Birmaher et al., 1998). In addition, an association of major depres-
sive disorders to anxiety disorders and substance use disorders has been de-
scribed (Rao et al., 1995, Pine et al., 1998, Lewinsohn 2000b) but few solid conclu-
sions can be made on the relationships of early-onset depressive disorders and 
other mental health disorders. It has been suggested, that anxiety is a precursor 
for depression, possibly due shared genetic diathesis, while the association of 
depression and behavioral disorders and substance use could be a result of famil-
ial risk factors, such as violence or parental substance use (Fergusson et al., 2002). 
Interestingly, the most recent report from Great Smoky Mountain Study (Cope-
land et al., 2009) did not found support for a link between adolescent and young 
adult depression. In this well known longitudinal population-based study, co-
morbidity of adolescent depression accounted entirely the predictive associations 
between adolescent and young adulthood depression, further highlighting the 
need to understand comorbidity during developmental years. 
4.7 Depressive disorders and attention deficit hyperactivity 
disorder (ADHD)
4.7.1 Definition, etiology and pathology of ADHD 
Attention deficit hyperactivity disorder (ADHD) is a common neurobehavioral 
disorder which is characterized by different manifestations of inattentiveness 
and hyperactivity-impulsivity symptoms across childhood, adolescence and 
adulthood (Barkley et al., 2008). In adolescence, these symptoms may have a per-
vasive effect on adolescents’ academic achievements and cause adverse effects in 
family and social environments. The etiology is a complex, poorly understood 
interplay of early genetic and environmental effects mediated by neurocognitive 
processes. Secondary and tertiary influences from environment (toxins, harsh 
parenting) have been identified.
4.7.2 Rates, course and assessments of ADHD in adolescents. 
Rates of attention deficit hyperactivity disorder vary from 1% to 8.5% (Barkley, 
1998, Froehlich et al., 2007, Smalley et al., 2007), depending on the age, and diag-
nostic approach. ADHD is a symptom –based diagnosis, requiring the presence 
of either inattentive or hyperactivity symptoms or both in addition to symptom 
pervasiveness, impairment and an age of onset prior 7 years. ICD-10 description 
refers to hyperkinetic disorder, requiring all three symptom types and excluding 
other disorders such as anxiety. However, DSM-IV excludes ADHD only if it is 
not better explained by other disorder. In practice, the ICD-category is a sub-
group of DSM-IV ADHD. Evidence of scientific validity of subgroups is just start-
ing to accumulate, but the so far is inconclusive. The validity of inattentive type 
of ADHD is questioned most. However, inattentiveness, such as distractibility, 
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failure to complete work and disorganization, seems to associate to risks of aca-
demic and social underachievement (Solanto et al., 2000). Pure hyperactivity is 
also troublesome to distinguish from oppositional deficit disorder. Assessments 
of ADHD in school-age adolescents can be obtained from parent and teachers’ 
reports showing good sensitivity and specificity (Stein and Perrin 2003, Taylor et 
al., 2004). However, an interview with parent allowing clinical judgment is the 
most reliable method.
Solid scienticific evidence shows that ADHD continues to adulthood among 50-
60% of the cases (Faraone et al., 1996, Hill and Schoener 1996, Spencer et al., 1996, 
Barkley, 2002). It is of concern, that non-referred adolescents outside clinical set-
tings and with high levels of symptoms without diagnosis, show academic un-
derachievement, continue to be socially impaired, unemployed, without friends, 
have motor accidents and develop aggressive, antisocial behavior and delinquen-
cy (Farrington, 1995). Symptoms of ADHD disappear (or the presentation chang-
es) when individuals age; previous research suggests that 3-5% of individuals in 
adulthood still have ADHD (National Comorbidity Survey, Kessler et al., 2006) 
The persistence of ADHD symptoms from childhood to adolescence has been 
reported also among 457 Finnish adolescents (Hurtig et al., 2007) but little is 
known about this disease in general population during transition to adulthood. 
ADHD is considered to be a phenomenon with male predominance, and only 
recently, the literature has been extended to females. The female-male ratios 
range from 10:1 of (clinical samples) to 3:1(community samples). Clinical experi-
ence has demonstrated the importance and burden of ADHD also among females 
(Quinn et al, 2005). In the large population-based sample of US children, in which 
8.7% of the 8-15 year-olds met the diagnostic criteria for ADHD, only 47% of the 
children had been diagnosed previously. Girls were less likely to have their dis-
orders identified previously and sex ratio was, suggesting referral bias unfavor-
able to girls, nearly 1:1 (Froehlich et al., 2007). Overall, epidemiological data 
shows discrepancies among females, since the estimations among women exceed 
those observed in girls (Arnold, 1996, Barbaresi et al., 2002). Previous research in 
Finland suggests a male-female ratio of 5.7:1 in general population (Smalley et al., 
2007, Hurtig et al., 2007)
4.7.3 The relationships of ADHD, depressive disorders and 
substance use 
Other neurodevelopmental disorders and early-onset as well as late-onset psy-
chiatric problems associate frequently to ADHD in clinical samples. Of these co-
existing conditions, substance abuse and substance use disorders underscore the 
public heath importance of understanding ADHD in the context of associated 
problems (Elkins 2007, Upadhyaya 2008, Bukstein 2008, Wilens, 2008) Comorbid 
states are also clinically significant and they may require careful monitoring of 
medication (MTA group, 1999). The importance of substance use related comor-
bidity with ADHD is one of the most relevant comorbidities in ADHD, since clin-
ical sample assessments suggest that medication of ADHD could have an impact 
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for later substance use. However, larger samples without referral bias need to be 
followed-up to provided additional data to confirm these findings (Volkow and 
Swanson, 2009).
In clinically ascertained reports, girls with ADHD may be at higher risk than 
boys for substance use disorders, especially in early adolescence (Biederman et 
al., 2004). However, girls in clinical settings may be more severely affected and 
their assessments may not sufficiently characterize attention-hyperactivity/im-
pulsivity spectrum in females (Gaub & Carlson 1997). Only few studies have as-
sessed large-scale population-based samples of boys and girls; Disney et al., 1999 
studying 632 girls, found some suggestion that girls with ADHD may be at high-
er risk for substance use than boys, albeit in this substudy of Minnesota Twin 
Family Study (Disney et al., 1999), the association of ADHD symptoms and sub-
stance use in adolescence was mediated through conduct disorder. A recent study 
from the same population source suggested that even a single symptom of ADHD 
independently predicted poor substance use outcome, and concluded that the 
association of ADHD and substance use may have not been observed consist-
ently in previous literature when studying less-sensitive diagnostic categories 
(Elkins et al., 2007). In majority of studies, designs are not gender-balanced, and 
the data of girls is combined with boys for purposes of statistical analysis.
Based on previous scarce research, comorbidity between depressive disorders 
and ADHD may be clinically significant phenomena (Daviss et al., 2008). How-
ever, many studies suffer from small sample sizes, referral biases, differences in 
diagnostic procedures and possible rater influences (Rucklidge, 2008). Concur-
rent comorbidity has been stated before, and is especially common in clinical 
settings; in general population conduct disorders, oppositional defiant disorders 
(Dick et al., 2005) as well as mild depression (Hurtig et al., 2007) may associate 
with symptoms of ADHD in adolescents. Just recently, diagnosed and followed 
up in psychiatric settings, Biederman et al. (2008) state that females with ADHD 
had a 2.5 times higher risk for major depression at adolescent follow-up com-
pared with control females. However, the research evidence on the association 
between depressive disorders and attention deficit/hyperactivity disorders is 
relatively new, and more studies are needed to establish these relationships. 
4.8 Depressive disorders and substance use in adolescence
“Smokers may be more prone to depression than nonsmokers,” “Or, people 
with depression may be self-medicating by smoking, albeit in a deadly way.” 
Edward Levin, Ph.D, professor of psychiatry, psychological and brain sciences http://fds.
duke.edu/db/aas/pn/faculty/adlevin
“Marijuana is not the answer. Too many young people are making a bad situa-
tion worse by using marijuana in a misguided effort to relieve their symptoms 
of depression,” “Parents must not dismiss teen moodiness as a passing phase. 
Look closely at your teen’s behavior because it could be a sign of something 
more serious.” John P. Walters, Director, National Drug Control Policy.
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4.8.1 Theoretical frameworks of addiction
Based on cross-sectional settings, it seems justified to assume that there is sig-
nificant comorbidity between adolescent depression and substance use. Howev-
er, whether depression causes the use of addictive substances, smoking, smoke-
less tobacco, alcohol and illicit drugs, is far more controversial. (Armstrong et al., 
2002, Niemelä et al., 2006).
The main hypotheses are: 
1. Self-medication; a theory according to which addictive substances are used to 
alleviate psychological symptoms (West et al., 2006). This theory focuses on 
finding similarities between neurobiology of depression and substance use. 
For example nicotine, a powerful stimulant, increases dopamine, serotonin, 
and noradrenalin known from their antidepressant effects and seems to affect 
the same regions in the brain that appear to be involved in regulating the 
mood, modifying the chemical imbalances of these neurotransmitters. 
2. An alternative hypothesis that baseline substance use is a determinant for 
later psychiatric symptoms and disorders, such as depressive disorders (Bre-
slau et al., 1998, Whitfield et al., 2000). The extension of this hypothesis is the 
opponent process theory of nicotine addiction (Solomon and Corbit 1973), ac-
cording to which negative consequenses of smoking could increase over time, 
as depressive mood (opposing state for initial pleasure state) becomes domi-
nant with regular smoking.
3. The theory on common vulnerability, according to which common factors, for 
example genetic factors could predispose to both depression and substance 
use. These two may be correlated, or joined together by genetic factors in-
volved in dopamine transmission.
Further, the pathways between mental disorders and substance use may be influ-
enced also by confounding factors. Given the high comorbidity of adolescent de-
pression, it is also of great importance to look for potential mediators in these 
associations. For example, depression could lead to alcohol use, but not without 
the presence of conduct disorder in individuals.
4.8.2 Diagnostic criteria for adolescent substance abuse and 
dependence according to DSM-IV
The current diagnostic criteria according to DSM-IV for substance abuse derived 
from adults include a maladaptive pattern of substance use leading to clinically 
significant impairment or distress, as manifested by recurrent substance use a) 
resulting in failure to fulfil major obligations at work, school or home, b) in situa-
tions in which it is physically hazardous (driving), c) relates to legal problems .d) 
or continues despite having persistent or recurrent social or interpersonal prob-
lems caused by the effects of substance.
Substance dependence is a maladaptive pattern leading to clinically significant im-
pairment and distress, requiring also three of the following in the same 12-month 
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period: 1) tolerance, 2)withdrawal; both tolerance & withdrawal representing 
physiological dependence if present, 3)a behaviour in which the substance is of-
ten taken in larger amounts or over a longer period than was intended, 4) a per-
sistent desire or unsuccessful efforts to cut down or control substance use 5)a 
great deal of time is spent in activities necessary to obtain the substance 6) impor-
tant social, occupational or recreational activities are given up or reduced be-
cause of substance use 7) continuation of substance use despite the knowledge of 
having persistent or recurrent physical or psychological problem that is likely to 
be caused or exacerbated by the substance (APA,1994). 
The research has considered reconceptualization of substance use disorders in 
adolescents focusing on tolerance, withdrawal and negative consequences of sub-
stance use (Martin et. al, 2006, Crowley, 2006.) However, the empirical studies to 
change and develop the current diagnostic criteria are lacking.
4.8.3 Implications for assessments of adolescent substance use 
behaviors
Alcohol and use of other psychoactive potentially active substances is a signifi-
cant public health problem. However, the criteria for substance abuse and de-
pendence are not generally met and the adolescents are not usually appreciative 
for assessments or treatment. Not all symptoms are a prodrome for dependence 
(Practice guidelines for the treatment of substance use disorders in DSM-IV-TR, 
APA, 2006), but initial use of substances, often on a trial basis, may escalate as a 
graduate process to a full level of dependence (Orleans and Slade 1993). Thus, the 
assessments of frequency, quantity and duration of substance use may have im-
portance in a developmental period of adolescence when substance use habits are 
established although uniform criteria for substance use is lacking. In adolescence, 
transition from use to abuse and sometimes even dependence occurs even in 
shorter time periods. Previous research demonstrates that substance misuse be-
low the diagnostic requirements needs to be considered as risk behavior in ado-
lescents (Rohde et al., 1996, Harrison et al., 1998). Adolescents may have a devel-
oping problem with substance dependence but not meet criteria for either sub-
stance abuse or dependence (Deas, 2006). Thus, If looking at diagnostic categories 
for substance use disorders, youth at risk for substance use disorders as well as 
those with already harmful substance use won’t be identified nor receiving much 
needed interventions. 
Assessment of adolescent substance use is not straightforward. Face-to face inter-
views may lead to underreporting of substance use by adolescents while self-re-
port data obtained by questionnaire yields more accurate information (Gforoer 
et. al., 2006) In the USA, the discrepancy between self-report to other informants 
has guided different research strategies to assess adolescent substance use. For 
example, during an interview, a self-reported questionnaire on drug abuse his-
tory can be administered, then a computer self-administered interview, ideally 
supplemented by toxicology laboratory screens (Turner et al., 1998). 
28
Early-onset depressive disorders, related disorders and substance use
4.8.4 The relationship of depression and smoking behavior  
in adolescence
Smoking is to be seen as a major public health concern due its several adversities. 
In terms of psychological correlates, co-occurrence with depressive disorders, as 
well as other psychiatric morbidity, is well documented (Brown et al., 1996, Fer-
gusson et al., 1998, Breslau et al., 1998. Previous studies among Finnish adoles-
cents emphasize the role of smoking as a robust marker for subsequent psycho-
pathology, such as suicidal acts, and severe substance-use related problems (Ria-
la et al., 2004, 2007). Previously, an increase in smoking among Finnish girls was 
reported (Rimpelä et al., 2002), but the current data suggests that the trend is 
declining (Adolescent Health Habit and Life Style Survey, Rimpelä et al., 2007).
Smoking frequency among Finnish adolescents may be lower than in the past, 
but still almost 25% of 16-18-year-olds smoke (Rimpelä et al., 2007).
Prospective studies during adolescence, in a developmental window for both de-
pressive disorders and smoking behavior, have yielded inconclusive results re-
garding this important relationship. Previous research on relationships between 
depression and smoking in adolescence has suggested bi-directional causation, 
such that depression increases the risk for smoking, while regular smoking also 
can lead to depressive episodes (Patton et al., 1998, Wang at al., 1999, Wu & An-
thony 1999, Goodman & Capitman 2000, King et al., 2004, Rice et al., 2007) and 
reciprocal relationships (Windle &Windle 2001). Depression may also increase 
the risk for smoking initiation (Brown et al., 1996, Kandel & Davies 1986). Com-
mon vulnerability for depression and smoking has been documented in adult 
females (Kendler et al., 1993), although not all findings support this hypothesis 
(Dierker et al., 2002).Other hypotheses, e.g., depression enhances genetic predis-
positions for smoking, emphasize the importance of early-onset depression in 
developmental trajectories of substance use (Audrain Mc Govern et al., 2004). Re-
cently, it has also been suggested that the association of depression and smoking 
could be stronger among females than males (Duncan & Rees 2005, Steuber & 
Danner 2006).
4.8.5 The relationship of depression and alcohol use in adolescence
According to last survey of Adolescent Health and Life Style Survey, 60 % of 
14-year-old Finish adolescents abstain from alcohol, but only 40% of the 16-year-
olds.However, the drunkenness-oriented drinking may be increasing, especially 
in 18-year-old boys. 
International studies document the undeniable association of alcohol use and 
depression (Lewinsohn et al., 1993a, Feehan et al., 1994, Newman et al., 1996, Ro-
hde et al., 1996, Costello et al., 1999, Kandel et al., 1997). The trajectories for drink-
ing in adolescence are poorly understood. One possibility from an etiological 
perspective is that alcohol may be consumed because of expectations that it re-
lieves depressive mood, a hypothesis described as a negative affect regulation 
model or self-medication (Sher et al., 2004). Previous studies suggest that early 
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symptoms of depression may associate also with later alcohol use in children and 
adolescents (Wu et al., 1999, Kumpulainen et al., 2002, Aalto-Setälä et al., 2002), 
but perhaps, only when associated with high levels of conduct disorder symp-
toms (Pardini et al., 2007).While alcohol appears to be a consequence of depres-
sion, it can also lead to negative life events that precipitate depression (Libby et 
al., 2005, Kuo et al., 2006). It is also possible, that life events associating to later 
problematic alcohol use, such as a loss or a separation from a biological parent 
(Isohanni et al., 1994, Seljamo et al., 2006) may be linked to adolescent depression. 
4.8.6 The relationship of depression and smokeless tobacco use in 
adolescence
Despite efforts to ban its use, smokeless tobacco is used in Finland in early ado-
lescence, especially among boys and athletes (Haukkala et al., 2006). Smoke-free 
laws make it impossible to smoke and the price of cigarettes has increased leav-
ing smokeless tobacco as an alternative to smoking. Among 18-year-old Finnish 
boys, 42% of the boys had experimented smokeless tobacco (Rimpelä et al., 2005).
The Adolescent Health and Lifetime Survey 2007 suggested that the use of smoke-
less tobacco may be increasing among Finnish girls (Rimpelä et al., 2007). The 
physical consequences are well known, increased heart rate, receding gums and 
oral cancer being then most commonly known to associate to smokeless tobacco 
use. However, smokeless tobacco may have effects other than direct adverse 
physical health-related consequences similar to smoking cigarettes, cross-sec-
tional designs suggest that smokeless tobacco may also associate with mood-re-
lated symptoms (Coogan et al., 2000, Tercyak et al., 2002).Whether it potentially 
contributes to nicotine dependence is, unclear (Haukkala et al., 2006) and more 
studies are warranted.
4.8.7 The relationship of depression and illicit drug use in 
adolescence
Among US adolescents, at least some lifetime use of illicit drugs was found 
among over 20 % of the 8th grade students (age 13-14) Johnston et al., 2006). The 
results of the same study also suggested that most adolescents that have used il-
licit drugs have used it rarely, while there was a smaller minority who reported 
relatively frequent use. In the European School Survey Project on Alcohol and 
Drugs (ESPAD), 11% of Finnish adolescents, mostly age 15-16 had used cannabis 
and 3% reported the use of other type of illicit drug (Metso et al., 2009). 
Depressive disorders and illicit drug use covary in epidemiological studies con-
ducted in adults, but links between them in adolescence are less clear. Previous 
studies have reported on early drug use as a predictor of depression (Brook et al., 
1998, Lynskey et al., 2004, Hayatbakhsh et al., 2007) but the role of adolescent de-
pression as a risk factor for later drug use has received less attention. However, a 
preliminary finding among adolescents in residential treatment showed that 
baseline depressive symptoms predicted poor substance use treatment outcome 
(Subramaniam et al., 2007). Further, childhood symptoms of depression and anx-
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iety were associated with ecstasy use in adolescents and adults in a population-
based Dutch sample (Huizink et al., 2006). 
4.9 Depressive disorders and eating disorders in 
adolescence
4.9.1. The prevalence and incidence of eating disorders 
Eating disorders (ED) are debilitating illnesses that generally develop in adoles-
cence. Strikingly, there are few studies assessing adolescents, and virtually no 
reliable estimates of prevalence or incidence of these disorders during adoles-
cence. Finnish longitudinal twin studies form older age cohorts (FinnTwin16, 
Keski-Rahkonen et al., 2007) have established the lifetime prevalence of 2.2. % for 
anorexia nervosa and 2.3% for bulimia nervosa in Finnish females. In Finnish 
males, EDs are rare, at least in the context of symptom presentation of current 
diagnostic requirements (Raevuori et al., 2009). Bulimia and bulimic symptoms 
may be more common than previously thought in adolescence; prevalence rates 
of 1.8% for females and 0.3% for males have been reported (Kaltiala-Heino et al., 
1999). International comparisons suggest that in a high-risk group of adolescent 
and young adult females the prevalence of anorexia nervosa is 0-0.9% (Hoek, 
2006). A large longitudinal study of the Dunedin cohort (Silva and Stanton, 1997, 
Arsenault et al., 2000) showed that by the age of 21, 1.4% of the females have de-
veloped an eating disorder. 
The true incidences are still unknown and depend much of the sampling and as-
sessments (Treatment guidelines for DSM-IV-TR disorders, Compendium APA, 
2006). In Finland, incidence for anorexia nervosa was 490/100 000 person years 
(Keski-Rahkonen et al, 2007) and 300 /100 000 person years for BN (Keski-Rahko-
nen et al., 2008). A recent study among Finnish adolescents (Isomaa et al., 2009) 
suggested substantially higher incidences compared to previous international 
(Hoek and van Hoeken, 2006) and Finnish studies (Keski-Rahkonen et al., 2007). 
More studies are warranted to confirm whether rates of these disorders are un-
derestimated in adolescence. 
4.9.2 The developmental and clinical features eating disorders 
during adolescence
Eating disorders during adolescence have particular developmental features. 
First, partial syndromes are of importance as they may represent the same im-
pairment levels as stringent diagnostic categories (Patton et al., 2008). Most ado-
lescents fail to fulfill stringent criteria for anorexia or bulimia nervosa: instead, 
they receive the diagnosis “eating disorders not otherwise specified, (EDNOS)”. 
This heterogeneous category includes a wide range of eating pathology.  Binge 
eating disorder may also occurs in adolescence (Fairburn, 2000), but it thought to 
be relatively rare. An unpublished population finding among under 30-year-olds 
suggest that prevalence of BED is 0.3% in Finnish population. (Keski-Rahkonen et 
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al., unpublished observation). In adults, EDNOS is the most commonly encoun-
tered type of eating disorders in clinical practice (Fairburn et al., 2007, Machado, 
2007, Eddy, 2008), possibly because it captures individuals with unremitting 
symptoms and individual migrated between the diagnostic categories (Hoek, 
2006). In adolescents, roughly 50-60% of cases may belong to this category (Ni-
cholls et al., 2000, Fairburn et al., 2005). Previous literature suggests that sub-
threshold cases, for example cases that fail to meet the frequency for binges or 
weight criteria for anorexia, warrant the same clinical attention than diagnostic 
cases (Crow et al., 2002, Fairburn et al., 2007, Stice et al., 2009). On the other hand, 
those with less severe, possibly self-limitating illness should be distinguish from 
more severe cases. A challenge presented by adolescence is presence of norma-
tive concerns about their changing body weight and shape, which need to be 
distinguished from extreme and rigid attitudes in eating disorder sufferers. Fur-
ther, the developmental stage, which often means pursuing independence from 
parents, needs to be taken into account in assessment and management of adoles-
cent-onset eating disorders. 
The clinical presentation of eating disorders in adolescence includes typical core 
eating disorder pathology, binge-eating, vomiting, laxative use, extreme exercise, 
self-judgment and evaluation by weight or shape (Fairburn, 2005). The male-fe-
male ratio in adolescence may be lower than 10:1, established in adult literature 
(Doyle and Bryant-Waugh, 2000). There also seems to be a subgroup of eating 
disorder patients among whom impulsive behaviors; such as self-mutilation and 
substance use are frequent (Boisseau, 2009). Personality styles similar to adults 
have been described (Thompson-Brenner et al., 2008). Some cases are self-limit-
ing while others, especially prepubertal cases may be life threatening (Strober, 
1997, Råstam, 2003). Those cases that do continue to adulthood are usually self-
perpetuating and respond poorly to treatment. 
4.9.3 The relationship of eating disorders, depressive disorders and 
associated disorders
Eating disorders associate with mood disorders, especially depression and anxi-
ety. Other axis -I disorders, such as anxiety disorders, especially social phobia as 
well as personality disorders and traits (Johnson et al., 2002, Salbach –Andrae, 
2008,) relate to adolescent eating disorders. In clinical practice, symptoms of anx-
iety and depression are common in patients, especially in patients with bulimia 
nervosa. Psychiatric comorbidity among eating disorders patients indicates a 
treatment contact (Fairburn et al., 1996). In practice, comorbidity often associated 
to more severe illness and may complicate treatment of eating disorders. The 
causes for this are not well understood. Biological and psychological factors com-
bine mood and eating behavior. The common neurotransmitters regulating both 
mood and eating have facilitated the understanding of these phenomena but the 
deeper nature of the covariation between depressive disorders and eating disor-
ders is unknown. It is possible that depressive disorders predispose vulnerable 
individuals to eating disorders. Reverse causation is also possible: persistent eat-
ing disorders can lead to depressive disorders. The comorbid pattern may also 
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derive from shared vulnerability of the disorders, in which case the same under-
lying factors would regulate both conditions (Keel et al., 2005, Wade et al., 2000, 
Lilenfield et al., 1998). 
Adult studies suggest significant comorbidity between eating disorders and de-
pression, possibly due shared genetic factors (Braun et al., 1994, Walters & Kend-
ler 1995, Wade et al., 2000, Mangweth 2003). 
In juvenile girls, clinical and epidemiological studies suggest associations be-
tween symptoms of eating disorders and depression in adolescents (Rowe et al., 
2002, Silberg et al., 2005, Marmorstein et al., 2008). Despite substantial documen-
tation of the association between depressive disorders and eating disorders the 
developmental relationships of juvenile eating disorders and other mental disor-
ders are poorly understood. Eating disorders and depressive disorders are un-
likely to have simultaneous onset, but the sequence in the development of these 
disorders remains unknown because of inconclusive and mixed results. In some 
studies, eating disorders have preceded other forms of psychopathology (Ivars-
son et al., 2000, Stice et al., 2001, Marmorstein et al., 2008), while in others, eating 
disorders have followed the same disorders (Johnson et al., 2002, Measelle et al., 
2006, Silberg et al., 2005, Biederman et al., 2007). Only one study has explored the 
possible causes behind the associations of depressive disorders and eating disor-
ders in juvenile girls, suggesting a distinct genetic effect in early adolescence and 
shared environmental effects in later adolescence (Silberg et al., 2005).
4.10 Genetic epidemiology studies in the covariation of 
depression, related disorders and substance use 
4.10.1 Defining genetic epidemiology
Genetic epidemiology aims to differentiate the effects of genes and environment, 
in order to primarily estimate the amount of genetic factors (Morton, 1982). Re-
cently, it has become easier to examine individual gene variants to in relation to 
disease outcome and to investigate the causal role of environmental factors. Fur-
ther, genetic approaches can be used to map out the role of environmental factors 
in the etiology of mental illness in people with different genetic profiles. It seems 
that the advances in genome revelation have added value of longitudinal genetic 
epidemiology research providing links for clinical psychiatry.
4.10.2 Genetic epidemiology studies of depressive disorders in 
adolescence
Depressive disorders in adolescence show high heritability indicating high ge-
netic loading, number of studies reporting heritability in range of 60-80% (Thapar 
and McGuffin 1994, Eaves et al., 1997, Hudziak et al., 2000, Happonen et al., 2002, 
Scourfield et al., 2003). Differences in these estimates exist due different measure-
ments, age groups, instruments and informants (Thapar and McGuffin 1994, 
Todd and Botteron 2001, Rice et al., 2002, Thapar and Rice, 2006). Changes in the 
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importance of genetic and environmental influences across development have 
been documented; the adolescent onset depressive symptomatology has a higher 
heritability than child-onset symptoms (Scourfield et al., 2003).  At ages 8-11, en-
vironmental factors may contribute to depression substantially more than ge-
netic effects (Eley et al., 1998, Thapar and MCGuffin, 1994). The study of Scourfield 
et al. (2003) suggested that the influence of shared environment is more impor-
tant in prepupertal children compared to adolescents, for whom the non-shared 
environmental factors are more important. Among subject of current thesis, Min-
na Happonen found that estimates of additive genetic effects were significant for 
depressive symptoms for both boys and girls at the age of 11-12, ranging from 
28% to 71%. Significant common environmental effects were found only in MNPI 
rating s’ of teachers and parents. (Happonen et al., 2002) Due to these past efforts 
of genetic epidemiology studies trying to understand the nature of early-onset 
depressive disorder, they have become a focus for genetic linkage and association 
studies (Wigg et al., 2009). 
4.10.3 Genetic epidemiology studies on substance use in 
adolescence
Adolescent initiation of substance use, a powerful predictor of adult substance 
use diagnosis, is influenced primarily by environmental rather than genetic fac-
tors (Mc Gue et al 2000, Han et al., 2002).However, in adolescence influences 
change through development; familial environmental factors are critical in influ-
encing use in early adolescence and gradually decline in importance through 
young adulthood. Genetic factors, by contrast, have little or no influence on sub-
stance use (tobacco, alcohol and cannabis) in early adolescence but it seems that 
they gradually increase in their effect with increasing age (Kendler et al., 2008). 
The substantial correlations seen in levels of substance use in across substances 
are largely the result of social environmental factors in adolescence, with genetic 
factors becoming progressively more important through early and middle adult-
hood (Mc Gue et al 2000,Han et al., 2002, Kendler et al ., 2008, Hopfer at al., 2008). 
The high correlation of genetic factors across ages suggests that early use may 
sometimes signal an early expression of a developmentally stable genetic predis-
position (Derringer et al., 2008). Data from longitudinal Finnish Twin Studies 
suggests the importance of genetic effects on drinking patterns increasing dra-
matically from adolescence to young adulthood (Rose et al., 2001). At age 14, ge-
netic influences accounted for only 18% of the variance in drinking initiation in 
girls, by age 18 genetic factors accounted for half of the variation. Conversely, the 
importance of common environmental effects decreased significantly from ado-
lescence into adulthood, accounting for>70% of the variance at age 14, but only 
~15% of the variance by age 18. Along with traditional twin modeling of the esti-
mates, there has been increasing interest indentifying the specific environments 
that influence substance behavior, and how these environments interact with ge-
netic predispositions (Dick et al., 2007).
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4.10.4 Genetic and environmental effects in the covariation of 
depression and substance use
Once comorbidity is established, several etiologic mechanisms are possible; in 
addition to bidirectional causal pathways, the co-occurrence of two distinct dis-
orders may be caused by third underlying factor, such as common genes which 
may increase the risk for both these disorders. Former twin studies in the field of 
depression and substance use aim to evaluate the genetic and environmental ef-
fects on the covariation of two diseases (Han et al., 1999, Kaprio et al., 1995, McGue 
et al., 2000, Kendler et al., 2003, Kuo et al 2006, McCaffery et al., 2008). Unfortu-
nately, most genetic epidemiology studies studying depression, related disorders 
and substance use have focused on adults. An exception is Virginia Twin Study 
of Adolescent Behavioral Development (VTSABD). The investigators of the study, 
Silberg et al., (2004) have evaluated causes of association between substance use 
and both conduct disturbance (CD) and depression in adolescent boys and girls. 
The patterns of correlations across the two waves of this study were consistent 
with conduct disturbance leading to substance use in both males and females, 
but depression leading to smoking, drug use and, to a lesser extent, alcohol use in 
girls. In this study, the co-occurrence in both disorders partially reflected a 
shared liability but, in girls, genetic influences played an important role in the 
comorbidity involving depression, whereas in both sexes (but especially in boys) 
environmental factors played a substantial role. The National Longitudinal Study 
of Adolescent Health (Add Health, Harris et al., 2003), has evaluated relationship 
of depression and smoking in adolescence suggesting significant non-shared en-
vironmental correlations and, only in females the existence of common genetic 
vulnerability (Mc Caffery et al., 2008). 
4.10.5 Discordant twin methods
Besides causal models, it is of importance to enhance understanding of the role of 
familial factors, such as childhood environment or dispositional genetic factors. 
Twins represent a pair of individuals naturally matched on both their genetic 
background and their shared environment. The method is based on identifying 
discordance; namely the pairs, in which the other twin is diagnosed with the ill-
ness while the co-twin is not. Thus, studying twins discordant for particular dis-
orders offers an elegant way to control familial background, e.g., family struc-
ture, status, and parental history (Dick et al., 2005, Eriksson et al., 2005). In brief, 
if the within-twin-pair analyses replicate the association found among twins as 
individuals, it rules out the confounding effects associated with shared family 
background, i.e. family structure or family history of disorder. The importance of 
these tests is highlighted, since most of the prospective associations in clinical 
patients and population rests in individuals.This method has been used in Finn-
ish Twin Cohorts previously, adjusting for family-within confounds, Korhonen et 
al., (2007 ) found that in twins discordant for illicit drug use, early smoking was 
a significant predictor.
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4.10.6 Gene and environmental interactions
Teasing apart genetic and environmental factors on behavior is not straightfor-
ward because of the likelihood that genes correlate with environment. Genes 
may influence sensitivity to the environment (Eaves et al., 2003) and heritability 
may vary according to environmental circumstances. Further, genetic risks for 
an outcome may also be expressed through greater exposure towards environ-
mental stressors (gene-environment correlation, rGE) (Rutter et al., 2006). Adoles-
cents at genetic risk for depressive phenotypes may be exposed to increased so-
cial adversity (rGE) and more susceptible to developing symptoms in response to 
these risks (G x E) (Caspi et al., 2003, Lay and Eley 2008). 
The genotype x environment interaction (G x E), can also be used when trying to 
resolve pathways affecting to the development of a specific outcome. To site an 
example, how genes and environment affect complex behavior; genetic differ-
ences in anxiety create later genetic differences in depression, genes that affect 
early anxiety increase sensitivity (G × E) to adverse life events; and genes that 
increase risk to early anxiety increase exposure to depressogenic environmental 
influences (rGE). Thus, additional genetic effects, specific to depression, further 
increase sensitivity to adversity. Most studies are only ongoing in this field, but 
the importance of gene x environment interaction is highlighted in modern ge-
netic epidemiology.
4.11 Motivation for the study
Previous prospective longitudinal studies have not yet given conclusive results 
regarding the role of early-onset depressive disorders in adolescence which is a 
period of rapid growth and maturation. Few studies have taken into considera-
tion the changes across development, as different influences specific to a certain 
age may exist. Age- standardized samples minimize the variation due age differ-
ences, but are rarely used. Besides the conclusion that depressed do not seem to 
outgrow their symptoms and are at risk for major depression in adulthood (Fo-
gel, 2006), many of the maladjustment and adversities related to early depres-
sions are not sufficiently documented. Clinical samples that deepen the under-
standing of depressive disorders and their clinical correlates among those who 
seek treatment may be vulnerable to referral bias. A large number of adolescents 
have depression never assessed and their implications to mental health and fi-
nancial cost are poorly understood. Some studies provide only a retrospective 
view for younger age groups, which further affect reliability of reports. Solid 
descriptive statistics of older age groups in Finland have been described (Aalto-
Setälä et al 2002, Haarasilta et al., 2001) but a limited number of comparable lon-
gitudinal assessments studying outcomes of early onset depressive disorders in 
adolescence have been documented. Although a growing body of evidence sup-
ports the importance of clinically relevant stress associated with minor depres-
sion among adolescents (Gonzalez-Tejera et al., 2005), only cross-sectional and 
short-term results are currently available.
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The substance use prevention programs are not as successful in girls as they are 
in boys (Kumpfer at al., 2008). Previous literature may have failed to take into ac-
count the role of depression, body image, social assertiveness and gender-based 
differences in developing substance use. In many clinical but also community-
based samples, examining disorders with male predominance, the amount of 
girls is insufficient or they are omitted. Further, the girls referred to assessments, 
for example depression and conduct disorders may already be severely affected 
and do not represent the disease in population level. However, even if the depres-
sive disorders do not lead to treatment, the depression itself, and the behavioral 
combinations with other psychiatric disorders may have far-reaching, under-
studied consequences later on. Attention-deficits are poorly understood among 
girls and treatment is usually delayed (Quinn, 2005). Gender differences are sus-
pected among subjects with ADHD regarding substance use (Disney, 1999) how-
ever, the small number of categorical diagnoses in young girls prohibits com-
parisons to boys in most samples.
Overall, most previous works conducted in genetically informative samples are 
adult samples. It is not likely, that the results would be applicable to adolescents 
since key risk exposures interplay with genes and are likely to vary across devel-
opment (Vineis and Kriebel, 2006, Dick et al. 2007). Controlling the shared famil-
ial factors has not been extended to adolescents, and their role in genetically in-
formative samples, such as adolescent twin samples is virtually unknown. Yet it 
clearly is of great importance to assess the role shared familial factors among 
young people. 
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5. Aims of the study
The study aimed to investigate early-onset depressive disorders, their relation-
ship to other mental health disorders and developing substance use in a prospec-
tive, longitudinal setting in a population derived sample. 
 
The study consisted of four substudies, which addressed the following:
1. Is minor depressive disorder clinically significant in adolescents and what is its relation-
ship to major depressive disorder (MDD)? (I)
2. Do early-onset depressive disorders relate to ADhD and substance use? Are there gen-
der differences in these potential associations and does CD modify this comorbidity? (II)
3. Are early-onset depressive disorders of importance in developmental trajectories of 
smoking behavior, illicit drug use, smokeless tobacco use, alcohol use and intoxication and 
eating disorders? 
Are these prospective associations explained by differences in the familial factors; genes, 
family structure or family income supporting future adverse behaviors? (III)
4. Do early-onset disorders associate prospectively and longitudinally to developing eating 
disorders? (Iv)
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6. Methods
6.1 FinnTwin 12 study -A longitudinal Twin Family Design 
Figure 1. Flow Chart. Overview of data collection for all twin families in FinnTwin 12
6.2 Sample and procedure
From 1994 to 1998, all Finnish families with twins born in 1983-87 were identified 
from Finland’s Central Population Registry and enrolled into a two-stage sam-
pling design (Kaprio et al, 2002). The first-stage study included extensive ques-
tionnaire assessments of some 5600 twins and their biological parents at baseline 
(87% participation rate, 2724 families) conducted during the late autumn of the 
year in which consecutive twin cohorts reached 11 years, with follow-up of all 
twins at ages 14 and 17½. 
Nested within this population representative study was an intensive assessment 
of a sub-sample of 1035 families, comprising about 40% of all twins, most (72.3%; 
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748 families) selected at random. About one-quarter of the sub-sample (27.7%; 287 
families) was enriched with twins assumed to be at elevated familial risk for al-
coholism, based on one or both parents’ elevated scores on an 11-item lifetime 
version of the Malmö-modified Michigan Alcoholism Screening Test (Seppä et 
al.,1990). The study has carefully assessed the differences between the total ran-
dom sub-set and enriched sample and no statistical differences has been found 
between any of the variables assessed in these substudies. The reviewers of each 
sub-study have had access of total comparison data of the total sample and the 
enriched sample. Thus, all the sub-studies present analysis of the full sample in 
order to retain maximum statistical power. 
Both co-twins and their parents from this sub-sample were interviewed using 
the SSAGA (Semi-Structured Assessment for the Genetics of Alcoholism, Buzholz 
et al 1994), a widely-used, reliable instrument providing lifetime diagnoses for 
alcohol abuse and dependence, major depressive disorder, anxiety disorders, 
conduct disorder, oppositional defiant disorder (ODD), attention-deficit-hyperac-
tivity disorder (ADHD) and eating disorders. The interview pays special atten-
tion to the interrelationship of substance use and psychiatric diagnoses but be-
cause SSAGA is a comprehensive interview, it can be used in other types of stud-
ies where substance abuse but is not necessarily the main focus of the study 
(Schuckit, 1995, Hesselbrock et al. 1999). Assessments of non-responders at each 
stage revealed no evidence of selection associated with family structure, parental 
age, residential area, type or sex of the twins, or other systematic bias. All inter-
viewers had previous interview experience and were Masters of Psychology, 
Health Care, or registered nurses; they were trained at Indiana University’s Insti-
tute of Psychiatric Research at Indiana University’s Institute of Psychiatric Re-
search using standard COGA-interview training procedures and were super-
vised by an experienced psychiatrist, Dr. John Nurnberger, Jr. (Edenberg, 2002). 
The mean age at interview was 14.19 years, with 75% of interviews completed 
between 14.0 and 14.3 months of age, and all interviews completed before age 15. 
The final interview sample (1852) consisted of 945 boys (51%) and 907 girls (49%), 
a participation rate of 90%.
Subsequently, during 2000 - 2005 at the average age of 17½, twin participants 
from all five birth cohorts were approached again with a mailed follow-up ques-
tionnaire including substance use assessments. A total of 1545 interviewed ado-
lescents (83% participation rate) born 1983-87 replied at age 17 (754 females, 49% 
and 791 males, 51%). Non-respondents did not significantly differ from respond-
ents in baseline depression status, sex, or age. 
Zygosity of twins was determined from well-validated questionnaire method 
supplemented by information from parents, photographs and genotyping (Gold-
smith, 1990, Kaprio et al., 1995). Data collection procedures were approved by the 
Ethics Committee of the University of Helsinki and by the Institutional Review 
Board of Indiana University, Bloomington. 
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6.3 Relevant data collection procedures for current study
This study collected data from multiple informants. Figure 2 presents is an over-
view of the data collection. From here on, only relevant parts of measures uti-
lized in current thesis are described detailed.
Figure 2. Flow Chart. Relevant data collection procedures and 
sampling for substudies of early-onset depressive disorders in first  
three waves of FinnTwin12. 
6.4 Assessments of adolescent mental health in FinnTwin12
Several measures of adolescent mental health were available. From baseline as-
sessments at ages 11-12 (Figure 1) the Teacher Rating forms of MNPI were used 
and are henceforth described more detail. At age 14, a polydiagnostic interview 
(SSAGA), highly standardized for adolescents’ age, using DSM-classification was 
conducted. The diagnostic system at the intake was DSM-III-R; however, many 
disorders could be scored for DSM-IV diagnosis as well. The SSAGA provided 
diagnoses and symptom counts for psychiatric disorders including alcohol abuse 
and dependence and general information of adolescent’s mental health such as, 
medical history information, and suicide attempts. This study also utilized infor-
mation from questionnaire assessments from first three waves (ages 11, 14, 17½) 
including wide range of questions related to mental health and substance use.
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from Finland’s Central Population 
Register  
Both twins alive &residents in 
Finland 
2,724 (87%) of families responded to 
initial family questionnaire, 1,035 
families were selected for intensive 
assessments 
2.070 twins were selected, 1852 (90%) were 
interviewed at average age 14.19y, 945 
(51%) girls, 907 (49%) boys  
Final Study group at follow up 
1545 twins replied to follow-up 
questionnaire (83%) at average age 17.5, 
754 (49%) girls, 791 (51%) boys  
307 did not reply to 
follow-up 
218 could not be 
reached/refused 
MNPI at age 12, completed by 90% of the teachers 
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6.4.1 Depressive disorders, suicidality, treatment seeking and 
medication
At age 14, both co-twins and their parents from this sub-sample were interviewed 
using the Finnish translation of the adolescent SSAGA (C-SSAGA-A, Semi-Struc-
tured Assessment for the Genetics of Alcoholism) providing diagnostic informa-
tion on all criteria of DSM-IV (Diagnostic and Statistical Manual of Mental Disor-
ders, 4th edn) major depressive disorder (MDD). Because of the low prevalence of 
DSM-IV MDD, (2.32%) and the clinical significance of minor depressive disorder 
in adolescents (Kessler at al., Gonzalez-Tejera et al 2005), we chose to include mi-
nor depressive disorder cases along with major depressive disorder cases in our 
analyses under the heading Depressive Disorder (DD). Minor depressive disor-
der (MD) was defined as meeting all criteria for MDD, except for the number of 
symptoms required. MD required the presence of at least two symptoms of MDD, 
one of them being depressed/irritable mood or anhedonia nearly every day for at 
least two weeks, and excluding adolescents with a previous history of DSM-IV 
MDD or dysthymia (presence of depressed/irritable mood nearly every day over 
a year and a report of at least two additional symptoms). All cases of depressive 
disorders were classified as early-onset depressive disorder cases. 
6.4.2. Suicidality, treatment seeking and medication
In addition to diagnostic information of depressive disorders The SSAGA inter-
view includes questions on service use, medication and suicide plans, suicide 
attempts and the severity of attempt from scale 0 to 4. All positive responses were 
asked to be explained in detail (Kuperman et al., 2001).
Appendix 1. Suicidality, treatment seeking and medication assessments in SSAGA.
When you were depressed (thinking of those at least two weeks when things 
were really tough on you at age x..)
Were there times when you wished you were dead?
Did you think a lot about death or dying?
Did you think about a way to kill yourself?
Did you try to kill yourself?
Suicidal attempts:
Have you ever tried to kill yourself?
How many times?
How old were you? Could you tell me what happened?
Life danger during attempt
No Danger .................................................................................................1
Went to a doctor .......................................................................................2
Was admitted to a hospital .....................................................................3
Was treated at intensive care unit .........................................................4
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Unknown...................................................................................................9
Severity of attempt
 Denies being serious ..........................................................................1
 Says that was serious only at some level, but not really ...............2
 Says it was for real, but is ambivalent .............................................3
 Says it was serious attempt to take one’s life ..................................4
Treatment seeking & Medication
Talking about those at least two weeks you were depressed and things were 
 really hard on you..
Did you have a doctor’s appointment or appointment with some other profes-
sionals?
Were you given medication for your symptoms?
How many times did you see a doctor on this?
Were you admitted to a hospital?
How long did you stayed at the hospital?
Did they give you any medication at the hospital?
6.4.3 Related mental health disorders and symptoms
6.4.3.1 ADhD and ADhD symptoms
At age 11-12, A multinomial peer nomination inventory (MNPI) and its parallel 
versions-MNPI Teacher and MNPI parental Rating Forms were administered to 
twins. MNPI was developed for Finnish Twin cohorts by professor Lea Pulkkin-
en (Pulkkinen, 1987) and has high reliability, internal consistency and discrimi-
native validity (Pulkkinen et al., 1999). It includes three dimensions; 1) behav-
ioural problems; inattention, hyperactivity, impulsivity and aggression and ad-
justment; 2) constructiveness, compliance and social activity and 3) emotional 
problems; depression and anxiety. The original MNPI included 30 items, in de-
veloping this instrument for Finnish Twin sample, additional items were added 
to Teacher Rating Forms and Parental Forms to enrich the coverage of ADHD, 
depression and anxiety, tested and refined in pilot studies to be appropriate for 
age , following closely the DSM-IV descriptions.. Further analysis has demon-
strated its ability to differentiate behavioural problems, e.g. aggression from hy-
peractivity (Pulkkinen et al., 1999). In MNPI, teachers rating items are presented 
in the form of statements (e.g., is hyperactive, does not wait for his turn). The 
teachers were asked to rate each twin on every item on a four point scale where 
0=does not apply, 1=applies sometimes, 2=certainly applies, 3=applies in a pro-
nounced way. 
At age 14, the diagnosis of ADHD was made according to DSM-III-R, the diagnos-
tic system in use, when planning the design of the current study and when the 
intake began. DSM-III-R does not take into account subtypes of ADHD, and lacks 
symptoms of current classification, thus diagnosis of ADHD was not made for 
DSM-IV. However, studying symptoms was prompted by the suggestions of pre-
vious research (Elkins et al., 2007) confirming that symptoms of ADHD by diag-
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nostic interview have proven useful, and the dimensional variables of inatten-
tiveness and hyperactivity may be more informative in ADHD than less sensitive 
diagnostic category.  
6.4.3.2 Oppositional defiant disorder, generalized anxiety disorders and conduct  
disorders
At age 14, based in semi-structured interview, the other major types of disorders; 
generalized anxiety disorder (GAD), ODD and conduct disorder, as were ana-
lyzed according to DSM-IIIR/ DSM-IV criteria.
6.4.3.3 Eating disorders
At age 14, eating disorders were at were analyzed in the same interview (SSAGA) 
using both full DSM-IV criteria and broader ad-hoc definition (meeting at least 
2/4 of current diagnostic criteria). At age 17 ½ the adolescents were asked: Do you 
have or do you think that you have ever had an eating disorder? 6 alternatives 
were given: 1) yes, anorexia nervosa, 2) yes, bulimia nervosa, 3) yes, both ano-
rexia and bulimia nervosa , 4) yes, an other type of an eating disorder, 5) I have 
not had an eating disorder and 6) I don’t know. The reliability of questionnaire 
assessments have been studied by authors in Finnish population previously and 
despite their simplicity, they showed satisfactory and more specific and sensitive 
detection of lifetime eating disorders compared to the longer and more elaborate 
EDI subscales (Keski-Rahkonen and Sihvola, 2006).
6.4.4 The assessments of substance use in FinnTwin12
6.4.4.1 Smoking behavior, smokeless tobacco, alcohol use disorders and illicit drug  
use at baseline
At age 14, adolescent tobacco use was measured by semi-structured interview at 
age 14., by multi-item non-diagnostic section of C-SSAGA-A, comprising of 23 
items assessing any use and regular use of tobacco products (cigarettes, smoke-
less tobacco, cigars, pipe), age of first and regular use , time since last use and 
amount, frequency and duration of regular use of each tobacco product. Based on 
those items, groups of experimenters, occasional and daily users were formed as 
well as users of smokeless tobacco. Illicit drug use was analyzed from its indi-
vidual section of semi-structured interview, and was defined as a report of use of 
any illicit drugs, such as marijuana, amphetamine, ecstasy, LSD, codeine or 
methadone. The never-smokers, never smokeless-tobacco users and those who 
had never used illicit drugs were used as reference group. Alcohol abuse and al-
cohol dependence were diagnosed according to DSM-III-R, based on diagnostic 
sections. 
6.4.4.2. Smoking behavior, smokeless tobacco, alcohol use and illicit drug use  
at follow-up 
Outcome variables at age 17½ were based on self-report questionnaire including 
detailed questions about substance use:
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Smoking behavior. “Have you ever tried smoking” and a multi-categorical fol-
low-up: “Which of the following best describes your current smoking”. The re-
sponse alternatives were: 1) I smoke 20 cigarettes or more/day; 2)10-19 cigarettes/
day; 3)1-9 cigarettes/day; 4) I smoke once a week or more often, not daily; 5) I 
smoke less than once a week; 6) I’m no longer smoking; and 7) I have experiment-
ed with smoking, but I don’t smoke. Alternatives 1, 2 and 3 were defined as daily 
smokers, 4 and 5 as occasional smokers; and 7 as experimenters. In multinomial 
regressions, the never smokers formed the reference group. In final models, when 
excluding previous users, the adolescents who were not currently smoking (6) 
were also excluded to avoid the inclusion of potential former heavy smokers.
Smokeless tobacco use. “Have you ever tried smokeless tobacco? How many 
times so far?” The alternatives were 1) No, I haven’t (defined as abstainers); 2) 
once (defined as experimenters); 3) 2-50 times; 4) more than 50 times; and 5) I use 
smokeless tobacco regularly. Alternatives 3), 4) and 5) were considered users. 
Those who had never used smokeless tobacco were defined as abstainers and 
formed the reference group.
illicit drug use. “Have you ever tried illicit drugs (marijuana, hash or similar 
drugs). Response options were: 1) never (abstainers); 2) 1-3 times (experimenters); 
3) 4-9 times or 10-19 times (moderate use); and 4) more than 20 times (frequent 
use). In multinomial regressions, the abstainers formed the reference group.
Alcohol use frequency and intoxication. “How often do you use alcohol, even in 
small amounts, like half a bottle of beer or a sip of wine?” and “How often do you 
use so much alcohol that you become intoxicated?” Nine response options were 
given: 1) daily; 2) a couple times a week; 3) once a week; 4) a couple times in a 
month; 5) once a month; 6) once in a couple months; 7) 2-4 times a year; 8) once a 
year or more rarely; and 9) I don’t use alcohol. In multinomial analyses, since only 
one person reported daily alcohol use, categories 1) and 2) were collapsed as fre-
quent users; 3), 4) and 5) as moderate users; 6), 7) and 8) as occasional users; and 
9) as abstainers. To assess intoxication, alternatives 1), 2), and 3) were considered 
frequent intoxication, 4), 5) and 6) were considered recurrent and 7), 8) as occa-
sional intoxication. In both drinking frequency and frequency of intoxication, 
alternative 9) was considered as abstaining and non-intoxicating, respectively, 
and used as reference category. 
6.5 Statistical methods
6.5.1. General biostatistics
Descriptive statistics in substudies I-IV were generated with Stata Software (Ver-
sions 8.2, and 9.2, Stata Corporation, College Station, TX, USA). For lifetime prev-
alences of minor and major depressive disorders and other psychiatric disorders, 
confidence intervals were calculated. Significant differences in means and distri-
butions between genders were tested with design-based F-tests and standard 
procedures for survey data (svy options is STATA). When appropriate, compari-
sons in subgroups, significant differences in means and distributions between 
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diagnostic groups were tested with two-sample Wilcoxon rank-sum (Mann-
Whitney) and Fisher’s exact tests. A probability level of p<0.05 (two-tailed) was 
considered statistically significant.
In all analysis considering individuals, the effect of twin study design on stand-
ard errors was taken into account by studying twin pairs as sample clusters (Wil-
liams, 2000, Woolridge, 2002) to adjust p-values and confidence intervals to cor-
rect for the non-independence of observations within twin pairs. The option clus-
ter in Stata (Stata, Stata Corp) takes into account the correlated nature of twin 
data, based on generalized estimation equations (Pickles, 1998). 
6.5.2 Logistic Regression Models 
The univariate and multivariate associations between baseline and follow-up 
variables were investigated using logistic regression models. Substance use out-
come measures at age 17.5 were multi-level and multinomial logistic regression 
models were applied to the data (substudies II, IV). Models were built sequen-
tially and odds ratios and 95% confidence intervals were calculated:
In substudy II, Significant differences in means and distributions between gen-
ders were tested with design-based F-tests and standard procedures for survey 
data (svy options is STATA). To study the relationships of DSM-IV based ADHD 
symptoms and substance use multinomial logistic regression was applied to 
data. First, a multinomial logistic regression model to study the association with 
the outcomes was examined. Second, potential confounding covariates of daily 
smoking behavior, illicit drug use, and comorbid psychiatric disorders were add-
ed to the model. To determine whether sex differences were present in the asso-
ciations, sex by diagnosis or sex by symptoms interaction terms were added to 
the logistic models. Given the rarity of reports describing female participants 
with externalizing symptoms and substance use outcomes, models were fit sepa-
rately for boys and girls. Gender differences were further tested with likelihood-
ratio tests to confirm significant differences between coefficients in models sepa-
rately fit to data from boys and girls.
In substudy III, univariate and multivariate associations of baseline early depres-
sive disorders with follow-up substance use were examined with multinomial 
logistic regression using never-users as the reference group. First, a multinomial 
logistic regression model to study the association of early-onset depressive disor-
der with the particular substance use outcome was examined. Second, potential 
confounding covariates (baseline alcohol use disorders, smoking, smokeless to-
bacco use, and illicit drug use) and comorbid psychiatric disorders were added to 
the model. Finally, to investigate whether early-onset depressive disorders also 
predicted substance use in those who were not users at baseline, users of each 
outcome variable in question, (for example, smokers at baseline when predicting 
future smoking) were excluded from the analysis.
In substudy IV, logistic regression analyses were conducted to test the predictive 
value of Axis-I disorders for the development of eating disorders. First, a uni-
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variate logistic regression model to study the association with eating disorder 
and another Axis-I disorder was examined. Second, other Axis I mental disor-
ders were added to the model. Finally, to investigate whether Axis I disorders 
also predicted eating disorders among those without eating disorders at baseline, 
the adolescents with baseline eating disorders were excluded from the analysis. 
6.5.3. Conditional logistic regression models (substudies III, IV)
In substudies III and IV, the investigation of whether the associations of inde-
pendent and dependent variables replicate after controlling for shared genes and 
shared family environments, including differences in family structure, status, 
parenting styles, parental models and family history, conditional logistic regres-
sion analyses were conducted among all informative twin pairs discordant for 
both predictor (early-onset depressive disorders at 14) and follow-up outcome 
(substance use or eating disorders at 17½). All within pair -models were built and 
tested similar to multivariate logistic regression models between pairs, with con-
ditioning on the twin pair. Odds ratios and 95 % confidence intervals were calcu-
lated.
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7. Results
7.1 Lifetime prevalences of minor depression and major 
depressive disorder by gender (i)
A large proportion of depressed adolescents fulfilled the criteria for potential 
valid subtype of depression for adolescents, minor depression. Exclusive to each 
other, the DSM-IV diagnosis of minor depression was substantially more com-
mon than major depressive disorder (12.0% vs. 2.3%). Lifetime prevalences of mi-
nor depression and major depressive disorder exhibit statistically significant gen-
der difference (P<.001) with female having a twofold difference for minor depres-
sion and fourfold for MDD (Table 1).
Table 1. Lifetime prevalences of minor depression (MD) and major depressive disorder 
(MDD) in 1852 14-year-old Finnish adolescents (mean 14.14) according to a semi-
structured interview
MD MDD
N Prevalence 
(%)
95%CI N Prevalence 
(%)
95%CI
TOTAL SAMPLE, 
N=1852 222 12.0 (10.5-13.5) 43 2.3 (1.6-3.1)
GIRLS, N=907 144 15.8 (13.5-18.2) 35 3.9 (2.6-5.1)
BOYS, N=945 78 8.3 (6.5-10.0) 8 0.9 (0.3-1.4)
F:M ratio 2.1 (1.5-2.8) 4.7 (2.2-10.1)
MD=minor depression, MDD=major depressive disorder, F: M ratio=female: male ratio, 
OR=odds ratio
7.2 Suicidality, treatment seeking and comorbidity among 
depressed youth
Subject with both diagnoses (MD and MDD) were considerably impaired and 
qualitatively similar. Suicidal ideation, suicide plans and suicide attempts were 
significantly associated to both minor depression and major depressive disorder. 
Most attempts were serious attempts of taking one’s life and 60% of them led to a 
contact with medical professional. Only a third of adolescents with major depres-
sive disorder had sought or been referred to a physician, due to their depressive 
condition. Suicidal ideation in the total interview sample of 1852 adolescents was 
6%, compared to 32% among adolescents with MD and 54% among those with 
MDD.
As expected, comorbidity was high, 30.6 % (68) with minor depression and 53.5% 
(23) of adolescents with DSM-IV MDD had at least one comorbid diagnosis. 21.7% 
(48) of minor depression and 30% (13) of MDD cases had one, 5.9% (13) and 14.0% 
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(6) had two, 2.3% (5) and 2.3% (1) had three, 0.9% (2) and 4.7% (2) had four lifetime 
comorbid diagnoses plus depressive disorder. Recurrence and low treatment 
seeking were associated with early-onset depressive disorders at the age of 14.
Table 2. Multivariate logistic regression for suicidality, service use among adolescents 
with minor depression (MD) and major depressive disorder (MDD).
MD MDD
% OR 95%CI % OR 95%CI
Suicidality
Ideation 31.8 27.5 (15.8-48.0)*** 53.5 14.3 (6.3-32.1)***
suicide plan 8.6 7.6 (3.6-16.3)*** 27.9 18.0 (5.9-54.3)***
suicide attempt 2.3 3.8 (1.0-14.4)* 11.6 12.3 (1.8-81.2)**
Service use
doctor’s appointment 6.8 4.9 (2.1-11.4)*** 32.6 26.8 10.1-71.3)***
antidepressant  
medication 1.4 8.0 (0.8-77.5) 4.7 22.0 (2.9-166.4)***
(All models were adjusted for sex and clustered sampling) MD=minor depression, 
MDD=major depressive disorder, OR=odds ratio
7.3 The concurrent and prospective relationships of early-
onset depressive disorders, ADHD and substance use (ii)
In multinomial logistic regression models adjusting for other psychiatric disor-
ders, the association of attention deficit/hyperactivity disorder and depressive 
disorders was significant only in girls (OR 2.06, 95%CI 1.38-3.07). When depres-
sion was present with ADHD, more than half (54%) of the girls, against 38% of the 
boys, smoked daily. In multinomial regression models, when comorbidity was 
taken into account, the combination of depressive disorders and ADHD increased 
concurrent risk for daily smoking nearly six-fold (OR 5.78, 95%CI 1.28-26.0) among 
girls compared to girls with neither disorder. 
At baseline age 11-12, parent and ratings of DSM-IV inattentiveness, hyperactiv-
ity and impulsiveness for boys were significantly higher (Design-based F-tests, 
all p<.001) compared to girls (table 1, substudy II). Substance use outcome of 
DSM-IV based ADHD symptoms was assessed at age 14 and 17.5.
Significant interactions with sex (p-level <.01) were present in multinomial logis-
tic regressions with baseline DSM-IV ADHD symptoms and follow-up interview 
assessments of illicit drug use and alcohol use disorders as well as illicit drug use 
and at age 17.5. Controlling for conduct disorder (CD), both teacher’s and parent’s 
report consistently predicted daily smoking behavior at age 14 among both boys 
and girls. Only among females were baseline DSM-IV ADHD-symptoms also 
prospectively associated with alcohol abuse and alcohol dependence diagnoses, 
and illicit drug use (table 2, substudy II). Gender differences were further tested 
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with likelihood-ratio tests to confirm significant differences between coefficients 
in models separately fit to data from boys and girls. At follow-up age 17.5, control-
ling for CD and previous substance use, baseline symptoms were significant pre-
dictors of frequent alcohol use (participants who reported alcohol use at several 
at least couple times a week) and illicit drug use (participants who reported il-
licit drug use more than 20 times) only in girls. Parents’ and teachers’ reports did 
not always mark a consistent pattern of substance use outcome, even though in 
many categories substance use outcome was unfavorable to girls compared to 
boys. Inattentiveness reported by both informants was a strong predictor of il-
licit drug use in young females across adolescence (table 2, substudy II). 
7.4 Early-onset depressive disorders and substance use (iii)
Early onset depressive disorder predicted elevated levels of use for measured 
outcomes of substance use/abuse at age 17½. Table 3 presents the distribution of 
the five outcomes; smoking behavior, smokeless tobacco use, illicit drug use, alco-
hol use and intoxication frequency by depressive disorder status at baseline age 
14. To cite an example, 39 % of adolescent twins with depressive disorders at age 
14 reported daily smoking at age 17½, compared to 26 % of adolescents without 
baseline depressive disorders, a 1.5 elevation in risk; 30.5 % of those without DD 
at baseline reported they were never smokers at follow-up, compared to less than 
20 % of those with baseline DD. Similarly, frequent use of illicit drugs at age 17 
was elevated 3.6 times among those with DD at age 14. Overall, early-onset de-
pressive disorders were robustly associated with elevated levels of addictive sub-
stance use, and, with but one exception, DD elevated prevalence of substance 
use/abuse consistently among both girls and boys. 
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Table 3. Distribution of all measured of levels smoking behavior, smokeless tobacco 
use, illicit drug use and alcohol use at three-year-follow-up (mean age 17.5) among 
adolescents with and without depressive disorders (DD, DSM-IV major or minor 
depressive disorder) at age 14. 
 DD at Baseline No baseline DD
females males all females males all
Smoking	behavior
		Never-smokers 18.8% 22.2% 19.9% 29.4% 31.5% 30.5%
		Experimentation 32.9% 27.8% 31.2% 33.4% 33.6% 33.5%
		Occasional 9.4% 9.7% 9.5% 11.2% 9.0% 10.0%
		Daily1 38.9% 40.3% 39.4% 26.0% 25.9% 26.0%
Smokeless	tobacco
		Never 76.0% 50.0% 67.6% 87.8% 61.7% 74.4%
		Experimentation 15.3% 11.1% 14.0% 7.3% 11.7% 9.6%
		Use 8.7% 38.9% 18.5% 4.9% 26.6% 16.0%
Illicit	drug	use
		Never 74.7% 86.0% 78.4% 87.1% 88.1% 87.6%
		Experimentation 17.3% 5.6% 13.5% 9.1% 8.2% 8.6%
		Moderate	(4-19	times) 4.7% 4.2% 4.5% 3.4% 2.2% 2.8%
		Frequent	(>20	times) 3.3% 4.2% 3.6% 0.5% 1.5% 1.0%
Alcohol	use
		Abstainers 10.7% 5.5% 9.0% 11.5% 12.5% 12.0%
		Occasional 21.3% 27.8% 23.4% 25.2% 21.5% 23.3%
		Moderate 60.0% 51.4% 57.2% 56.9% 57.9% 57.4%
		Frequent2 8.0% 15.3% 10.4% 6.4% 8.1% 7.3%
Intoxication
		Never 16.7% 11.1% 14.9% 21.9% 19.2% 20.5%
		Occasional 26	.7% 23.6% 25.7% 31.8% 27.9% 29.8%
		Recurrent3 50.0% 59.7% 53.2% 39.4% 45.4% 42.5%
		Frequent 6.6% 5.6% 6.2% 6.9% 7.5% 7.2%
In most cases, early onset depressive disorders associated longitudinally and 
prospectively to the most elevated levels of measures substance use outcome at 
age 17½ (Figure 3).
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Figure 3. The distribution of the significant outcomes at age 17½ by depressive disorder 
status at baseline age 14. 
DD=depressive disorders. Daily smoking = from 1 cigarette to over 20 cigarettes/day. 
Smokeless tobacco use 2-50 times or more, Frequent alcohol use= recurrent 
intoxication=couple times in a month to daily intoxication, Illicit drug use= used more 
than 20 times 
7.4.1 The prospective associations of early-onset 
depressive disorders and substance use 
In multinomial logistic regression models early-onset depressive disorders pre-
dicted daily smoking (odds ratio 2.29, 95%CI 1.49-3.50, p<.001), smokeless tobacco 
use (OR = 2.00, 95%CI 1.32-3.04, p=.001), frequent illicit drug use (OR = 4.71, 95%CI 
1.95-11.37, p=.001), frequent alcohol use (OR = 2.02, 95%CI 1.04-3.92, p=.037) and 
recurrent intoxication (OR = 1.83, 95%CI 1.18-2.85, p=.007) three years later.
The results remained significant after adjusting other psychiatric disorders and 
substance use disorders and more importantly, were replicated also among those 
without previous substance use.
In Table 4, model 1, which adjusted for sex differences and clustered sampling of 
twins, shows that at three-year follow-up, early-onset depressive disorders 
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strongly predicted all later substance use. Model 2 reports results of a model that 
adjusted for other early-onset psychiatric disorders, as well as all other types of 
previous substance use, and excluded all participants with previous use of a par-
ticular substance, for example previous smokers. Results from Model 2 suggest 
that depression predicted future daily smoking even among those who were not 
daily smokers at baseline. Similar patterns of significant associations after ex-
cluding baseline users were observed for smokeless tobacco use, frequent illicit 
drug use, frequent alcohol use and recurrent intoxication among adolescents.
Table 4. The Odds Ratios of multi-level smoking status, illicit drug use, smokeless 
tobacco use, alcohol frequency and intoxication at follow-up (age 17.5) according to 
early-onset depressive disorders at baseline (age 14) among Finnish twins born 1983-
87(N=1545).
Model 1 
(Bivariate OR, 95%CI)
Model 2 
(Multivariate OR, 95%CI)
OR 95%CI p OR 95%CI p
Smoking behavior
Never-smokers 1.00 1.00
Experimentation 1.40 .91-2.16 .127 1.28 .82-2.02 .278
Occasional 1.37 .77-2.44 .278 1.27 .68-2.36 .453
Daily 1 2.29 1.49-3.50 <.001 2.14 1.33-3.45 .002
Smokeless tobacco use
Never-users 1.00 1.00
Experimentation 1.88 1.20-2.96 .006 1.71 1.04-2.80 .035
Use 2.00 1.32-3.04 .001 2.08 1.31-3.29 .002
Illicit drug use
Never-users 1.00 1.00
Experimentation	 1.66 1.05-2.64 .030 1.38 .85-2.25 .191
Moderate	(4-19	times) 1.67 .80-3.45 .169 1.00 .41-2.40 .995
Frequent (>20 times) 4.71 1.95-11.37 .001 3.75 1.07-13.21 .039
Alcohol use 
Abstainers 1.00 1.00
Occasional	 1.31 .75-2.31 .344 1.31 .73-2.37 .355
Moderate	 1.32 .80-2.20 .279 1.24 .73-2.11 .419
Frequent 2 2.02 1.05-3.91 .036 2.14 1.00-4.57 .049
Intoxication
Never 1.00 1.00
Occasional	 1.19 .73-1.95 .481 1.17 .71-1.95 .533
Recurrent 3 1.83 1.18-2.85 .007 1.65 1.04-2.62 .034
Frequent	 1.26 .62-2.58 .526 .99 .43-2.27 .973
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7.4.2 Discordant twin analysis of early-onset depressive disorders 
and substance use
Analysis of twins discordant for early-onset depressive disorders confirm pre-
dictive associations of early-onset depressive disorders with smokeless tobacco 
use and frequent drinking at age 17½, in within-family replications with co-
twins matched on half or all their segregating genes, and on their family struc-
ture, socio-economic status, and household environment. 
The longitudinal association of depressive disorders and substance use was run 
in the same setting. In the total sample, 150 twin pairs were discordant for base-
line early-onset depressive disorders (i.e., one twin in each pair met criteria for 
DD while the co-twin did not); these 150 pairs formed the target study group for 
our within pair-analysis. Among these 150 pairs, we then identified the subset of 
pairs discordant as well for each substance use outcome at follow-up, asking of 
these informative pairs, whether it was the depressed co-twin that exhibited sub-
stance use/abuse at follow-up. 
For example, 46 of the 150 twin pairs discordant for depressive disorder at age 14 
were discordant as well for daily smoking at age 17½. And in 30 of these 46 dou-
bly discordant twin pairs, the co-twin depressed at baseline was the daily smok-
ing twin at follow-up (30/16 = unadjusted odds ratio = 1.875). Conditional logistic 
regression models were employed to adjust these odds ratios for sex differences 
and observed (Table 5) significant sex-adjusted associations for smokeless tobac-
co and frequent alcohol use. Additional conditional logistic regression analyses 
demonstrated that the relationships with smokeless tobacco and frequent alcohol 
use remained significant after excluding the opposite-sex twin pairs.
Table 5. Substance use outcomes at age 17½ in twin pairs (N=150 pairs) discordant for 
Early-Onset Depressive Disorders and substance use at follow-up.
No. of pairs* OR 95%CI
Daily Smoking 32/46 1.83 .98-3.42
Smokeless Tobacco 19/32 5.63 1.27-24.8
Drug Use 11/16 1.67 .40-6	97
Frequent Alcohol Use 14/22 3.75 1.07-13.20
Regular Drunkenness 31/56 1.43 .82-2.53
Abbreviations: CI=Confidence Intervals; OR=Odds Ratios.
*Fraction of pairs discordant both for depressive disorder at baseline and substance use at 
follow-up in which the co-twin depressed at baseline was the twin who met the substance 
use outcome. The odds ratios were calculated using conditional logistic regression. The 
odds ratios were adjusted for sex, other covariates examined were conduct disorder, atten-
tion-deficit (ADhD), oppositional-deficit (ODD), substance use and generalized anxiety 
disorders, but none were significant predictors. All models excluded baseline users.
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7.5 The prospective associations of early-onset depressive 
disorders, generalized anxiety disorders and eating 
disorders (iV)
7.5.1 Lifetime prevalences of DSM-IV anorexia nervosa and 
bulimia nervosa
Lifetime prevalences for DSM-IV anorexia and bulimia nervosa were 0.32% 
(95%CI 0.06-0.58) and 0.05 %( 95%CI 0-0.10), respectively. Broad syndromes, de-
fined ad-hoc as the presence of at least 2/4 current DSM-IV diagnostic criteria, 
were considerably more common (N=73, 3.9%).The most frequent eating disorder 
symptoms at the age of 14 were binge-eating, body image concerns and fear of 
gaining weight while being underweight.
Among 1545 adolescents at follow-up, the prevalences for self-reported anorexia 
and bulimia nervosa were 1.4 %( 95%CI 0.74-1.99) and 0.7 %( 95%CI 0.23-1.13), re-
spectively.
7.5.2 Early-onset depressive and generalized anxiety disorders as 
predictors of eating disorders in late adolescence
In longitudinal analysis, major depressive disorders and generalized anxiety dis-
orders at age 14 were strongly associated with eating disorders at follow-up at age 
17 ½. These relationships between generalized anxiety and EDs and depressive 
disorders and EDs were statistically significant also among those without base-
line eating disorders and eating disorder symptomatology. Because of high co-
morbidity of these two disorders, the sample was stratified based on lifetime di-
agnoses of major depressive disorders and generalized anxiety into four groups; 
those with neither baseline diagnosis, those with both , those with major depres-
sive disorders alone and those with generalized anxiety alone. The presence of 
major depressive disorder in combination with generalized anxiety disorder in-
creased the likelihood of future disorders compared to mood or anxiety disor-
ders alone (adjusted odds ratio, 11.3). The results remained significant after ad-
justment of other mental disorders at baseline and excluding baseline eating dis-
orders (Table 3, substudy 4). 
7.5.3 Early-onset depressive disorders as predictors of eating 
disorders in adolescence-discordant twin analysis
The prospective analysis of depressive disorders and eating disorders was then 
complimented by examining these associations within discordant twin pairs. 42 
pairs were identified to be discordant for eating disorders at follow-up, among 
them 10 sister-sister pairs were also discordant for baseline early-onset depressive 
disorders and generalized anxiety disorders and were analyzed further. In 8/10 
pairs it was the depressed one who went on developing an eating disorder while 
the co-twin, without any symptoms of ED of DD or GAD at baseline, stayed healthy.
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The main finding of discordant twin analysis was that within a twin pair with 
shared family background, the twin affected with depressive or generalized anx-
iety disorder was 4 times more likely to develop an eating disorder. In condi-
tional logistic regression models adjusted for sex and all other Axis-I disorders 
this translated to increased risks of co-twin with MDD (OR 1.29, 95%CI 1.02-1.64) 
and similar, but statistically nonsignificant trend of co-twin with GAD (OR 1.60, 
95%CI .75-3.43) for later eating disorders. Given the rarity of these traits in popu-
lation, the power of discordant analysis to exclude familial factors or established 
causality was limited. 
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8. Discussion
8.1 Summary of main findings 
8.1.1 Minor depressive disorder during adolescence- clinical 
correlates and adverse outcomes (I)
Although providing descriptive statistics was not a primary aim of the study, 
depressive conditions with impairment but below the diagnostic threshold of 
MDD, were relatively common among Finnish participants, similar to interna-
tional studies.( National Comorbidity Survey (Kessler et al.,1998, Lewinsohn et 
al., 2004). The results of the first substudy suggested that a categorical diagnosis 
of major depressive disorder reflects severe cases, but depressive conditions de-
fined according to diagnostic criteria for minor depression, with similar case 
definition of disability and distress, but with less number of symptoms, was also 
associated with important clinical correlates such as suicidality, comorbidity and 
recurrence resembling those meeting full diagnostic requirements for MDD. The 
findings are in line of minor depressive disorders in adulthood (Rapaport et al., 
2002) extending these findings to adolescents. 
Overall, the findings of the substudies of this thesis support the role of minor 
depression causing clinically relevant stress and psychiatric morbidity, in line 
with previous evidence from cross-sectional and short-term reports (Lewinsohn, 
2000, Cuijpers, 2004, Gonzalez-Tejera et al., 2005). 
The results do not imply that minor depression necessarily is a distinct condition. 
However, they established that this category represents clinically significant de-
pressive symptoms rather than evanescence in adolescence and further relates to 
hypothesis that psychiatric disorders manifest as a phenotypic continuum 
(Leigh, 2009). Further, the results also support a more dimensional approach to 
depression, as a spectrum of overlapping disorders, potentially ranging from bi-
polar I depression to major depressive disorder (Benazzi, 2006). Thus, developing 
better-fitting diagnostic models is essential for adolescents to provide accurate 
estimates for service planning.
8.1.2 The prospective relationships of depressive disorders, ADHD, 
symptoms of ADHD and substance misuse among adolescents (II)
While externalizing disorders, conduct disorders, and oppositional defiant disor-
ders were associated with ADHD in both boys and girls, the strong predictive 
and concurrent associations of ADHD with depressive disorders was found only 
in girls. That finding suggests that the awareness of this behavioral combination 
among girls may be important in the early identification of adolescent girls with 
ADHD in the community. The prospective analyses of substance use outcome of 
ADHD behaviors are limited to a 7 year time span; clearly, these results do not 
permit confident conclusions of causality. However, the short-term outcome of 
substance use of girls with ADHD symptoms was unfavorable: results from this 
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gender-balanced sample support prospective associations of symptoms of ADHD 
with alcohol abuse and alcohol dependence and frequent illicit drug use only 
among girls. The population-based findings from other cultures (Disney et al., 
1999, Elkins et al., 2007) are few, but suggestive that even symptoms of ADHD 
might predict substance abuse problems. This data adds substantial evidence in 
that girls may be at higher risk compared to boys, and that the girls’ risk may are 
not attenuated by conduct disorder, a strong predictor for substance abuse. The 
current analysis also suggest that dimensional predictors may be informative, 
perhaps more so than categorical diagnosis of ADHD. Further, restricting analy-
ses to diagnostic categories only may be misleading, since risk factors may oper-
ate across a range of these symptoms. 
This finding, even reported before in clinical sample (Biederman et al., 2008) has 
great provocasy. The potential unfavorable substance use outcome among girls 
warrants more studies in relations of externalizing conditions and substance use 
by gender. Medicalization of all ADHD symptoms is not advisable, but for the 
very least, whether early recognition and interventions among girls with behav-
ioral symptoms of ADHD hold potential for substance use prevention further in 
their lives calls for more research. 
8.1.3 Dual diagnosis - a self-medicating strategy or  
something else?
The results of third substudy suggested that early onset depressive disorders  signal 
the subsequent substance use; interestingly, most recent studies also confirm in-
creasing involvement of substance use among youth with early-onset depressive dis-
orders (Wu et al., 2008). In this study, many of the findings highlighted the impor-
tance of early-onset depressive disorders in non-referred adolescents as well as early 
symptoms since many were antecedents of future adverse outcomes. This seems to 
be a trend also in other recent epidemiological studies in Finnish adolescent samples. 
(Niemelä et al 2009, from boy to a man study, Huurre et al., 2009, in press).
In principal this speaks s for theoretical background of self-medicating  hypothesis; 
are young people making their situation worse as a misguided effort to relieve 
the symptoms of depression? The results are age-dependent, but it seems that 
depressed adolescents are in particular vulnerable. Interestingly, the results of 
this study have been recently confirmed in young males (Niemelä et al., 2009). 
However, none of the studies have been able to formally establish causality.
Analysis of twins discordant for early-onset depressive disorders confirm pre-
dictive associations of early-onset depressive disorders with smokeless tobacco 
use and frequent drinking at age 17½, in within-family replications with co-
twins matched on half or all their segregating genes, and on their family struc-
ture, socio-economic status, and household environment. Interestingly, the novel 
findings within the twin pair parallel the findings of individuals, allowing us to 
rule out the third confounding factor common to siblings. In this field, no compa-
rable previous results were available for familial aspects of disorders and health 
–related behaviors associated with early-onset depression. 
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Although exploratory, these findings do suggest that the association of depres-
sion and substance use is not explained by familial factors, such as family in-
come, instead the influence of peers or dispositional personality traits may be of 
importance. In the context of developmental theories, this could relate to in-
creased family conflicts and critical thinking which emerges in adolescence cre-
ating a heightened need for peer approval in adolescence. Severing family ties 
can further lead to over identification with the peer group, identity confusion and 
excessive rebellion. (Steinberg 1993).Thus, at least from a theoretical point of view, 
the importance of peers in developing substance use would be meaningful. 
Could a depressed individual be more vulnerable to those influences, perhaps 
due lower self-esteem? 
8.1.4 The prospective analysis of affective disorders and eating 
disorders 
Partial eating disorder syndromes were of importance representing the same im-
pairment levels as strict diagnostic categories. Although limited number of cases 
fulfilling diagnostic criteria for DSM-IV anorexia nervosa and bulimia nervosa 
prohibited formal comparisons, it was evident that broad syndromes were quali-
tatively similar to full disorders. Few comparable studies conducted in adoles-
cence strongly support these findings (Patton et al., 2008). However, it is likely, 
that broad categories also include individuals with less severe symptoms and 
both clinically significant and non-significant groups exist among adolescents 
not fulfilling the diagnostic criteria. Recent evaluations suggest, however, that 
the adolescent cases remaining in subthreshold categories have same features 
(Sancho et al., 2008, Schmidt et al., 2008) undergo the same developmental course, 
and thus may differ only in pathological severity from full syndromes.
The results showed that depressive disorders and generalized anxiety disorders 
were strongly associated to eating disorders in adolescence. The possible role of 
negative affect trait in causal processes and maintaining eating disorders (Stice 
et al., 2002) have been suggested and may associate to these findings. Even though 
eating disorders are not as common as mood disorders in adolescence in Finland, 
they are of great importance also because of these associations to concurrent and 
prospective psychopathology. The analyses also partially control for shared ge-
netic effects (the discordant twins included DZ twins, who share 50% of their 
genetic variation). Together with observed temporal precedence of generalized 
anxiety and eating disorders, these analyses suggest that early depression and 
generalized anxiety may be important factors in a causal pathway in developing 
eating disorders in adolescence. 
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8.2 Methodological considerations 
8.2.1 Strengths and limitations
The purpose of the study was to explore relationships of early-onset depressive 
disorders, other psychopathology and substance use in a gender-balanced sam-
ple of adolescents. The FinnTwin 12, a population based twin study served this 
purpose well, since it offers a rich design of professionally administered age-
standardized interview, as well a multiple source of other informants, such as 
parents and teachers. Thus, the study had good means of overcoming the bias 
cause by large age differences and under-balanced sex ratios. The high participa-
tion rates were also an advantage. Further, comorbidity was controlled for, which 
is of importance because evidence suggests linkage of substance use to several 
psychiatric disorders, especially externalizing disorders. Any relations observed 
between other psychiatric disorders and substance abuse in studies that fail to 
take into account the overlap with conduct disorder, a strong, well documented 
predictor for substance use, may be spurious (Flory& Lynam, 2003). Finally, the 
within-family analysis of depression-discordant twin pairs offered an incisive 
control of the role of familial factors in these developmental relationships. 
The twin studies have been criticized because of their alleged non-generalizabil-
ity due to differences in intrauterine and familial environments of twins com-
pared with singletons. However, research beginning early in life, demonstrates 
that the twins have similar emotional and behavioural problems, psychiatric 
symptoms (Kendler et al., 1995), and even similar brain volume measures 
(Hulshoff et al., 2002) compared to singletons.While the twinship must be consid-
ered as a limitation when interpreting the results of individual analyses, the pre-
vious literature as well as analysis from FT12 support the generalizability of the 
findings to adolescent population. The FinnTwin 12 study has a rich design mul-
tiple informants: the twins of the study had 23200 classmates (11903 boys and 
11297 girls) who participated in classroom evaluations which provided an oppor-
tunity to compare the behavioral differences between twins and singletons. 
These comparisons suggest that the differences between twins and singletons 
are small and they are highly similar in their behavior. The small differences 
suggested that twinship may be an advantage, as twins were more social com-
pared to their classmates (http://wiki.helsinki.fi/display/twinstudy/Kaksosten+ 
ke hi tys+ja+terveys+-tutkimus). Regarding adolescent depression, clear evidence 
for differences in rates of depression between twins and singletons has not been 
documented. A previous study of longitudinal samples of twins and singletons 
aged 8-17 found no differences between twins and singletons in their depression 
scale scores (Angold et al., 2002). In an earlier report of these same twins partici-
pating to FinnTwin12 at the age of 12, depressive symptoms did not differ in 
prevalence between them and 25 000 classmates (Pulkkinen et al., 2003). The re-
sults regarding the prevalence rates and clinical characteristics from this study of 
twins are consistent with those of other epidemiological studies (Lewinsohn et 
al., 1994, 2004, Ford et al., 2003) and depressive disorders among the twins are 
likely to be similar to those found in the nontwin population.
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Both using symptom rating scales and interviews as methods have their advan-
tages. The symptoms scales are sensitive and usually work well for screening and 
following up the changes in symptom profiles during interventions.  Semi-struc-
tured interview, used in the current study, however, provides diagnosis, with 
higher threshold and, higher specifity, probably resulting lower prevalences 
compared with self-reports of structured interviews. When compared with stud-
ies using similar methodology, the results are alike (Ford et al., 2003, Canino et al 
2004). The disadvantage of semi-structured interviews is non-cost-effectiveness 
and the demand of solid clinical expertise. In this study, the interviewers were 
highly skilled and well trained. 
Using self reports as follow-up assessments is an obvious limitation. However, 
evidence from Finnish population suggests that self-reports of smoking behav-
iour is correlates well to levels of cotinine in blood, and thus may a reliable meth-
od to address smoking behavior (Vartiainen et al., 2002). 
Although the primary aim of the study was not to provide estimates of preva-
lences of early-onset depressive disorders in Finnish population, specific consid-
erations for generalizability of the results are made. Most of the intensively stud-
ied subsample (72, 3%) was selected at random from population-based ascertain-
ment, but a part was enriched with a potential familial risk for alcoholism based 
of mMAST-screen of the parents. A series of model-fitting analyses to diverse 
phenotypes nave been performed to test for potential bias introduced by the 
sample enrichment, and no evidence that model-fitting results were systemati-
cally affected have been found(Rose et al., 2004). No significant differences be-
tween the mental health assessments, e.g. early-onset depressive disorders were 
found in direct comparisons of the subsample of enriched adolescents and the 
randomly selected subsample (Sihvola et al., 2008, complementary analyses). 
However, it is possible that the effects, perhaps in terms of increased liability for 
depression, will emerge later in life. 
The analyses of depression-discordant co-twins represents a new, and perhaps 
important effort in understanding the association of early-onset depressive dis-
orders and substance use in the context of familial confounds, but because of 
limited sample of doubly discordant pairs, the results should be viewed more 
suggestive than definitive. The findings confirmed significant associations of 
early-onset depressive disorders and use of smokeless tobacco and alcohol, but 
given the small number of informative twin pairs, the lack of association for oth-
er outcomes should not be interpreted as evidence that familial confounds under-
lie those associations. The power of further statistical analyses among MZ and 
DZ twins was inadequate and prohibited further conclusions about genetic fac-
tors.
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8.3 clinical implications
The importance of early onset depressive disorders in the trajectories of wide 
range of substance use has obvious important clinical implications for the pre-
vention of substance abuse among adolescents. Along with externalizing behav-
ior problems, including conduct, attention deficit hyperactivity, and oppositional 
defiant disorder, which all have been identified as strong predisposing risk fac-
tors for later substance use, adolescents with early-onset depressive disorders 
should be identified as at-risk group for developing substance use. However, the 
majority of the depressed youth reported impairment in several environments, 
but had too few depressive symptoms to fulfill the diagnostic criteria for major 
depressive disorder. Thus, reliance on less-sensitive categories among adoles-
cents is may cause failure to observe these important pathways, despite of obvi-
ous clinical utility of strict categories. The possible connection of common symp-
toms among adolescents, (such as representation of minor depression and ADHD 
behaviors) to substance use and substance use disorders in adolescence, in period 
for the foundation to substance use habits raises a substantial public health and 
clinical concern. Prevention, screening, identification and considering interven-
tion options should perhaps be extended beyond categorical diagnosis among 
youth. 
The potential unfavorable substance use outcome among girls with ADHD be-
haviors warrants more studies in joint relations of externalizing conditions and 
substance use by gender. Substance use prevention does not seem to be as effec-
tive in girls as it is in boys ((Kumpfer et al, 2008). and there may be underlying 
factors why substance use prevention programs are not equally successful among 
genders. Early identification and treatment of ADHD in girls may be of great 
importance for substance use prevention. For both boys and girls, screening of 
substance use along when attention-deficit hyperactivity disorder seems likely, 
would be worthwhile. 
Suggested by these results, developing elevated levels of addictive substance use, 
such as tobacco use, alcohol use, intoxication and illicit drug use among adoles-
cents with early-onset depressive disorders is not explained by familial factors 
supporting future substance use may also have important implications for sub-
stance use prevention programs in individuals during early adolescence. Treat-
ment programs among depressed or substance misusers could have a more syn-
ergetic point of view and co-operation between them should be emphasized, 
rather than separating treatment units for psychiatric care and substance use.
Diagnostic criteria for eating disorders should be carefully reassessed and, per-
haps, relaxed towards better understanding the nature of these diseases in ado-
lescence. The most severe cases are referred to specialized assessment and treat-
ment, but many remain unidentified and do not receive adequate interventions. 
Undiagnosed and undertreated comorbid psychiatric illnesses may also affect 
the outcome of treating eating disorders (Keski-Rahkonen et al., submitted). 
Therefore adolescents who exhibit depressive and/or anxiety disorders could 
also be screened for eating disorders. Clinical experience shows that the treat-
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ment and pharmacological and psychotherapeutic interventions of patients with 
comorbid eating disorder may differ from others and benefit from special exper-
tise. Valid preventive programs for eating disorders would require surveys on 
excessive scale, because eating disorders are relatively low prevalence illnesses. 
However, more careful screening is warranted in high-risk groups, for example 
young girls with depression.
8.4 implications for future research
Epidemiological studies: The long term mental health outcome of early-onset 
depressive disorders and the role of familial factors
The prospective analyses in this study are limited to a 7 year time span; clearly, 
these results do not permit confident conclusions of causality. However, the fol-
low-up of these individuals will hopefully address the substance use outcomes in 
adulthood. Studies with long-term follow-up should reveal the potential impor-
tance of early-onset disorders and whether or not they have an effect on partici-
pant’s lives in terms of substance use disorders as well as psychiatric disorders in 
adulthood.
One of the important finding of this study the was the significant longitudinal 
relationship of early-onset depressive disorders and substance use and other psy-
chiatric morbidity regardless of familial factors needs to be confirmed in future 
twin studies. The finding perse warrants further studies exploring factors such 
as dispositional personality traits, perhaps antisocial traits, and influence of 
peers on in the context of developing substance use. This study used novel meth-
ods aiming to test that outcome factors were not explained by 3rd confounding 
factors, however, more studies using new methods to test causal effects of envi-
ronmental factors on children and adolescents’ developmental outcomes are war-
ranted. 
From a more general point of view, further studies, examining etiology and de-
velopmental course of these diseases, beginning with at-risk children and adoles-
cents, earlier in development than current studies are of importance to deepen 
the life-span developmental conceptualizations of these diseases. An interesting 
question is, whether these early-onset illnesses at all represent the same illnesses 
as in adults, or whether they are in fact distinct disorders with different develop-
mental pathway and causalities compared to adult disorders.
Clinical studies; effectiveness of interventions of early-onset depressive  
disorders
This study offer an epidemiologic perspective to depressive disorders in adoles-
cent population, but it has implications for future studies with clinical approach. 
Many adolescent of the study had never been referred nor even told about the 
symptoms, however, they had relevant clinical distress and were showed to suf-
fer from adverse outcomes at follow-up. Thus, it would be important yet chal-
lenging, to study the potential interventions among them. Subclinical depres-
sions even with impairment in adolescence are rarely treated with medication in 
clinical settings, but whether or not they could benefit from a motivational inter-
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view, assessments of comorbid disorders, or psychotherapeutic interventions 
could be studied further. 
Substance use and gender issues
At present time, the participants of this study are in the process of follow-up at 
ages 20-24, in a known risk period for substance abuse (Hawkins et al., 1992, Bie-
derman et al., 1997).This study as well as other prospective longitudinal ongoing 
studies need to address the relationships of early-onset psychopathology to later-
onset substance use disorders. Evaluation, whether treatment of prior predictive 
psychopathology, for example depression, conduct problems or attention deficits 
has an effect on later risks on substance use seems crucial.
A research area that needs attention is gender differences in the relations among 
early-onset depressive disorders, attention deficit hyperactivity/impulsivity dis-
orders, eating disorders and substance use. It is plausible, that given the clear sex 
differences in prevalences of e.g. eating disorders and in adulthood substance 
abuse and dependence diagnoses (DSM-IV) there may be differential relations 
among them for males versus females. Categorical diagnoses of externalizing 
disorders are rare among females in the community, therefore large-scale studies 
are encouraged, since substance use is substantial public health concern, and in 
females it might also have particular significance to their offspring’s lives. It is 
unclear, whether young females would benefit from substance use preventive 
programs that are different from boys. Prospective research should extend 
through developmental years and include a sufficient number of both genders 
using multiple reporters to investigate these important relationships. Protective 
factors for substance use outcomes should also be studied, as they are an impor-
tant but neglected topic of research. 
8.5 conclusion
This study sought to address the important issue in the fields of early-onset de-
pressive disorders, related mental health disorders and developing substance use 
among adolescents. The relationships between the predictors and substance use, 
abuse and dependence outcome were studied over 1,500 individual twins fol-
lowed-up from 11 years of age through age 17½. This study provided novel find-
ings in concurrent and longitudinal relationships of early-onset depressive disor-
ders, ADHD, eating disorders and substance use, which may have important 
implications for future research, clinicians, mental health professionals and pub-
lic health. In conclusion, early-onset depressive disorders should be considered to 
be significantly related to future substance use behaviors among both boys and 
girls, similar to the better established relationships of externalizing disorders 
and substance use in adolescence. 
Minor depression has recently received international attention, (Johnson et al., 
2009) and it seems that this common condition may also have financial signifi-
cance related to severe cases of mental disorders. When data from a community-
based prospective longitudinal study from another culture were used to investi-
gate the association of minor depressive disorder during adolescence with ad-
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verse mental health outcomes during adulthood, the results indicated that minor 
depressive disorder during adolescence was associated with elevated risk for 
subsequent psychiatric disorders during adulthood, and clinically relevant im-
pairment after corresponding and co-occurring disorders were controlled statis-
tically (Johnson et al., 2009). Should an effort made to support these young peo-
ple, rather than only offer interventions to those with ‘serious’ depressive illness, 
severe problems with conduct and attention, and substance use disorders?
The prospective associations of early-onset depressive disorders to other mental 
health disorders received a special attention in substudies of this thesis. Interest-
ingly, many of these other, often co-morbid disorders among depressed signaled 
unfavorable outcome for substance use, although this data, in line with previous 
research (Hawkins 1992, Mc Gue 1997), clearly noted the powerfulness of conduct 
problems to substance use outcomes. This study had a comparable proportion of 
boys and girls, which helped to understand the potential gender differences in 
these relationships. Results from this sample, derived from a large nationwide 
population-based study support prospective associations of early-onset depres-
sive disorders and symptoms of ADHD, both associated with alcohol abuse and 
alcohol dependence and frequent illicit drug use among girls. This data adds 
substantial evidence in that girls with ADHD behaviors may be at higher risk 
compared to boys, and that the girls’ risk may are not attenuated by conduct dis-
order, a strong predictor for substance abuse. Inattentiveness especially may play 
more of a role in developing substance use than previously thought. Whether 
early recognition and interventions among girls with behavioral symptoms of 
ADHD hold potential for substance use prevention further in their lives calls for 
more research.
The study also took advantage of the genetically informative sample of twins, 
and explored these relationships among twin pairs discordant for diverse pheno-
types, using novel methodology to examine the outcomes of these illnesses while 
taking into account the shared familial factors. It is necessary to consider the in-
dependence of familial factors as an exploratory finding, which needs to be rep-
licated in future studies. However, the influence of peers as well as other environ-
mental factors, society in individuals, seems to be worth examining further, as 
well as exploring the effect of environmental influences to genetic background. 
Although these relatively short-term results (prospective analyses limited to 3-7 
year time span) warrant new studies and even larger samples with larger num-
bers of affected males and females are needed to truly determine the effect of sex 
on severe psychopathology, they represent important steps to deepen the under-
standing of longitudinal relationships of early-onset psychopathology, develop-
ing substance use and substance use disorders in the community. 
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